<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003078.pub2" GROUP_ID="RENAL" ID="912300031510103055" MERGED_FROM="" MODIFIED="2016-09-26 01:33:36 +0100" MODIFIED_BY="Narelle Willis" REVIEW_NO="011" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="14.0">
<COVER_SHEET MODIFIED="2016-09-26 10:32:00 +1000" MODIFIED_BY="Narelle Willis">
<TITLE MODIFIED="2009-01-06 10:47:50 +1100" MODIFIED_BY="[Empty name]">Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease</TITLE>
<CONTACT>
<PERSON ID="7342" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Conal</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Daly</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Nephrologist</POSITION>
<EMAIL_1>Conal.Daly@ggc.scot.nhs.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Renal Unit</DEPARTMENT>
<ORGANISATION>Western Infirmary Glasgow</ORGANISATION>
<ADDRESS_1>Dumbarton Rd</ADDRESS_1>
<ADDRESS_2/>
<CITY>Glasgow</CITY>
<ZIP>G11 6NT</ZIP>
<REGION>Scotland</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 141 2116310</PHONE_1>
<PHONE_2/>
<FAX_1>+44 141 2116308</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis">
<PERSON ID="7342" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Conal</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Daly</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Nephrologist</POSITION>
<EMAIL_1>Conal.Daly@ggc.scot.nhs.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Renal Unit</DEPARTMENT>
<ORGANISATION>Western Infirmary Glasgow</ORGANISATION>
<ADDRESS_1>Dumbarton Rd</ADDRESS_1>
<ADDRESS_2/>
<CITY>Glasgow</CITY>
<ZIP>G11 6NT</ZIP>
<REGION>Scotland</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 141 2116310</PHONE_1>
<PHONE_2/>
<FAX_1>+44 141 2116308</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7298" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>June</FIRST_NAME>
<MIDDLE_INITIALS>D</MIDDLE_INITIALS>
<LAST_NAME>Cody</LAST_NAME>
<SUFFIX/>
<POSITION>Review Author</POSITION>
<EMAIL_1>djunecody@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL>http://www.otago.ac.nz/cure</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Incontinence Review Group</DEPARTMENT>
<ORGANISATION>University of Aberdeen</ORGANISATION>
<ADDRESS_1>2nd Floor, Health Sciences Building</ADDRESS_1>
<ADDRESS_2>Health Sciences Building</ADDRESS_2>
<CITY>Foresterhill</CITY>
<ZIP>AB25 2ZD</ZIP>
<REGION>Aberdeen</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 1224 438126</PHONE_1>
<PHONE_2>+44 1224 438128</PHONE_2>
<FAX_1>+44 1224 438165</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7742" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Izhar</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Khan</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Nephologist</POSITION>
<EMAIL_1>izharkhan@nhs.net</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Medicine and Therapeutics</DEPARTMENT>
<ORGANISATION>University of Aberdeen</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Aberdeen</CITY>
<ZIP>AB25 2ZD</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 1224 552122</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="19790" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kannaiyan</FIRST_NAME>
<MIDDLE_INITIALS>S</MIDDLE_INITIALS>
<LAST_NAME>Rabindranath</LAST_NAME>
<SUFFIX>MRCP</SUFFIX>
<POSITION>Consultant Nephrologist</POSITION>
<EMAIL_1>ksrabi@yahoo.co.uk</EMAIL_1>
<EMAIL_2>samuelrabi@hotmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Renal Unit</DEPARTMENT>
<ORGANISATION>Waikato District Hospital</ORGANISATION>
<ADDRESS_1>Pembroke Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hamilton</CITY>
<ZIP>3240</ZIP>
<REGION/>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="9285" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Luke</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Vale</LAST_NAME>
<SUFFIX/>
<POSITION>Health Foundation Chair in Health Economics</POSITION>
<EMAIL_1>luke.vale@newcastle.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institute of Health &amp; Society</DEPARTMENT>
<ORGANISATION>Newcastle University</ORGANISATION>
<ADDRESS_1>Baddiley-Clarke Building, Richardson Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Newcastle upon Tyne</CITY>
<ZIP>NE2 4AX</ZIP>
<REGION>Tyne &amp; Wear</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>0191 2225590</PHONE_1>
<PHONE_2/>
<FAX_1>0191 2226043</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="8261" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Sheila</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Wallace</LAST_NAME>
<SUFFIX/>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>s.a.wallace@abdn.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Academic Urology Unit</DEPARTMENT>
<ORGANISATION>University of Aberdeen</ORGANISATION>
<ADDRESS_1>2nd Floor, Health Sciences Building</ADDRESS_1>
<ADDRESS_2>Foresterhill</ADDRESS_2>
<CITY>Aberdeen</CITY>
<ZIP>AB25 2ZD</ZIP>
<REGION>Scotland</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 1224 438119</PHONE_1>
<PHONE_2/>
<FAX_1>+44 1224 438165</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2016-09-22 16:36:07 +1000" MODIFIED_BY="Narelle S Willis">
<UP_TO_DATE>
<DATE DAY="22" MONTH="10" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="22" MONTH="10" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2001"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="8" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2016-09-26 10:32:00 +1000" MODIFIED_BY="Narelle Willis">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-09-26 10:32:00 +1000" MODIFIED_BY="Narelle Willis">
<DATE DAY="26" MONTH="9" YEAR="2016"/>
<DESCRIPTION>
<P>Minor edit to included and excluded studies</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="STABLE" MODIFIED="2016-09-22 16:45:50 +1000" MODIFIED_BY="Narelle S Willis">
<DATE DAY="22" MONTH="9" YEAR="2016"/>
<DESCRIPTION>
<P>There have been no new or ongoing studies since 1999, therefore this review is no longer being updated. Correa-Rotter 1997, listed as awaiting assessment has now been excluded</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-09-22 16:35:59 +1000" MODIFIED_BY="Narelle S Willis">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-09-22 16:35:59 +1000" MODIFIED_BY="Narelle S Willis">
<DATE DAY="25" MONTH="11" YEAR="2013"/>
<DESCRIPTION>
<P>Our conclusions remained unchanged</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-09-22 16:35:56 +1000" MODIFIED_BY="Narelle S Willis">
<DATE DAY="25" MONTH="11" YEAR="2013"/>
<DESCRIPTION>
<P>New search performed. In this 2013 updated review, we excluded six new trials (<LINK REF="STD-Bailie-1990" TYPE="STUDY">Bailie 1990</LINK>; <LINK REF="STD-Burkart-1990" TYPE="STUDY">Burkart 1990</LINK>; <LINK REF="STD-de-Fijter-1994" TYPE="STUDY">de Fijter 1994</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Tan-2005" TYPE="STUDY">Tan 2005</LINK>; <LINK REF="STD-Wong-2006" TYPE="STUDY">Wong 2006</LINK>); one is awaiting classification (Correa-Rotter 1997a).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-01-06 10:39:00 +1100" MODIFIED_BY="[Empty name]">
<DATE DAY="29" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-11-20 11:52:39 +1100" MODIFIED_BY="[Empty name]">
<DATE DAY="20" MONTH="11" YEAR="2005"/>
<DESCRIPTION>
<P>Searched for new trials, none identified</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of Aberdeen</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Health Services Research Unit</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Health Economics Research Unit</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>NHS Executive Research and Development Programme</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-09-23 10:18:55 +1000" MODIFIED_BY="Gail Y Higgins">
<SUMMARY MODIFIED="2008-09-29 11:48:26 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-09-29 11:48:26 +1000" MODIFIED_BY="[Empty name]">Y-set and double bag systems offer the most protection against peritonitis during continuous ambulatory peritoneal dialysis (CAPD)</TITLE>
<SUMMARY_BODY>
<P>People with advanced kidney disease may be treated with CAPD where a catheter is permanently inserted into the peritoneum (lining around abdominal contents) through the abdominal wall and sterile fluid is drained in and out a few times each day. The most common serious complication is infection of the peritoneum - peritonitis. This may be caused by bacteria accidentally being transferred from the catheter. This review of trials compared three types of connecting systems (used to connect the bags and the catheter) and found the Y-set and double bag exchange systems are the most effective in preventing peritonitis.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-11-28 11:39:06 +1100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-11-28 11:39:06 +1100" MODIFIED_BY="Ann Jones">
<P>Peritonitis is the most frequent serious complication of continuous ambulatory peritoneal dialysis (CAPD). It has a major influence on the number of patients switching from CAPD to haemodialysis and has probably restricted the wider acceptance and uptake of CAPD as an alternative mode of dialysis.</P>
<P>This is an update of a review first published in 2000.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>This systematic review sought to determine if modifications of the transfer set (Y-set or double bag systems) used in CAPD exchanges are associated with a reduction in peritonitis and an improvement in other relevant outcomes.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-11-18 15:59:37 +1100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Renal Group's Specialised Register through contact with the Trials Search Co-ordinator. Studies contained in the Specialised Register are identified through search strategies specifically designed for CENTRAL, MEDLINE and EMBASE. Date of last search: 22 October 2013.<BR/>
</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised controlled trials (RCTs) or quasi-RCTs comparing double bag, Y-set and standard peritoneal dialysis (PD) exchange systems in patients with end-stage kidney disease. <BR/> </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-09-29 13:50:51 +1000" MODIFIED_BY="[Empty name]">
<P>Data were abstracted by a single investigator onto a standard form and analysed by Review Manager. Analysis was by a random effects model and results were expressed as risk ratio (RR) or mean difference (MD) with 95% confidence intervals (CI).</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-11-18 15:50:31 +1100" MODIFIED_BY="Ann Jones">
<P>Twelve eligible trials with a total of 991 randomised patients were identified. Despite the large total number of patients, few trials covered the same interventions, small numbers of patients were enrolled in each trial and the methodological quality was suboptimal. Y-set and twin-bag systems were superior to conventional spike systems (7 trials, 485 patients, RR 0.64, 95% CI 0.53 to 0.77) in preventing peritonitis in PD.<BR/>
</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Disconnect systems should be the preferred exchange systems in CAPD. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-09-23 10:18:55 +1000" MODIFIED_BY="Gail Y Higgins">
<BACKGROUND>
<P>Continuous ambulatory peritoneal dialysis (CAPD) has been used as an alternative to haemodialysis for patients with end-stage renal disease (ESRD) since 1976 (<LINK REF="REF-Popovich-1976" TYPE="REFERENCE">Popovich 1976</LINK>). It may be used as the first choice dialysis therapy and in a number of countries including the United Kingdom a significant proportion of the ESRD population are treated by this modality in preference to chronic haemodialysis. A peritoneal dialysis (PD) exchange involves draining CAPD dialysate solution into and out of the peritoneal cavity using a permanently implanted PD catheter and a transfer or connection system. Peritonitis is the most common serious complication of PD and is the leading cause of technique failure requiring a switch to haemodialysis (<LINK REF="REF-CANUSA-1996" TYPE="REFERENCE">CANUSA 1996</LINK>). Undertaking a PD exchange is one of the key points during CAPD when micro-organisms can be inadvertently transferred via the lumen of the peritoneal catheter into the peritoneal space (intraluminal route) causing peritonitis. The CAPD transfer system used may therefore have an important bearing on both the incidence of peritonitis and CAPD technique failure. </P>
<P>There are three main types of catheter connecting systems. In the "standard" or straight connecting system the catheter is connected to the dialysate solution bag using a straight piece of tubing and a "spike" or a luer lock device. At each exchange a new connection is made and the bag is drained. The empty bag is rolled up and remains attached until the next exchange when the process is repeated. The second type of transfer system is the Y-set in which the patient disconnects (disconnect system) from the bags between exchanges. When a new exchange is due a Y-connection with one limb connected to an empty bag and one to a bag containing fresh dialysate is used (<LINK REF="REF-Buoncristiani-1980" TYPE="REFERENCE">Buoncristiani 1980</LINK>; <LINK REF="REF-Buoncristiani-1993" TYPE="REFERENCE">Buoncristiani 1993</LINK>; <LINK REF="REF-Buoncristiani-1996" TYPE="REFERENCE">Buoncristiani 1996</LINK>). During an exchange the peritoneal dialysate is first drained from the peritoneal cavity into the empty bag. Before introducing the fresh dialysis solution into the peritoneal cavity the Y-connecting system is first flushed with fresh dialysis solution and drained into the drainage bag. This allows any bacteria to be flushed into the spent fluid. The fresh fluid is then introduced into the peritoneal cavity and the Y-connector is disconnected from the CAPD catheter. The early Y-set technique, in addition, flushed the system with a disinfectant, a hypochlorite, during each exchange (<LINK REF="REF-Buoncristiani-1983" TYPE="REFERENCE">Buoncristiani 1983</LINK>). The third system, the double bag (twin bag) system, is a further development of the Y-set disconnect systems. With this system the connection with the fresh dialysis solution bag is already made and the patient has to perform one less connection procedure (<LINK REF="STD-Balteau-1991" TYPE="STUDY">Balteau 1991</LINK>; <LINK REF="REF-Bazzato-1980" TYPE="REFERENCE">Bazzato 1980</LINK>). It has been suggested that use of the Y-set transfer or double bag systems will lead to a reduced frequency of CAPD peritonitis (<LINK REF="REF-Buoncristiani-1983" TYPE="REFERENCE">Buoncristiani 1983</LINK>) and some (<LINK REF="REF-Golper-1996" TYPE="REFERENCE">Golper 1996</LINK>; <LINK REF="STD-Port-1992" TYPE="STUDY">Port 1992</LINK>) observational studies have indicated an association between use of the standard connect system and a significantly increased risk of peritonitis. At present a considerable proportion of CAPD patients, continue to use the standard system. Other techniques, such as the Ultraviolet Germicidal System (<LINK REF="REF-Churchill-1991" TYPE="REFERENCE">Churchill 1991</LINK>; <LINK REF="REF-Nolph-1985" TYPE="REFERENCE">Nolph 1985</LINK>), in-line bacteriological filters (<LINK REF="REF-Churchill-1991" TYPE="REFERENCE">Churchill 1991</LINK>; <LINK REF="REF-Slingeneyer-1983" TYPE="REFERENCE">Slingeneyer 1983</LINK>) and heat sterilisation (<LINK REF="REF-Churchill-1991" TYPE="REFERENCE">Churchill 1991</LINK>; <LINK REF="STD-Durand-1995" TYPE="STUDY">Durand 1995</LINK>) have been developed and used in an attempt to reduce peritonitis rates; they were not considered as part of this review.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To evaluate the evidence that supports the use of the Y-set (and modifications) and double bag systems for the prevention of peritonitis in PD patients. </P>
</OBJECTIVES>
<METHODS MODIFIED="2013-11-20 11:50:34 +1100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-09-29 11:49:00 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>All randomised controlled trials (RCTs) and quasi-RCTs investigating the effect of the Y-set or double-bag systems to prevent PD peritonitis. </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Adult and paediatric patients undergoing PD treatment. </P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-09-29 11:48:43 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Double bag (experimental group) and/or Y-set (experimental group) versus standard CAPD exchange systems (control group).</LI>
<LI>Double bag (experimental group) versus Y-set (control group).</LI>
</OL>
<P>We included studies where disinfectant had or had not been used to flush and/or to be retained in the elements of the Y-set system. For either the Y-set or double bag systems the sequence of the exchanges could vary:</P>
<OL>
<LI>drain/flush/fill or</LI>
<LI>flush/drain/fill.</LI>
</OL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-09-29 11:49:00 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Number of patients experiencing peritonitis and peritonitis rate (number of episodes per patient months on treatment) (primary outcome)</LI>
<LI>Number of patients experiencing exit-site/tunnel infections and exit-site/tunnel infection rate (number of episodes per patient months on treatment)</LI>
<LI>Number of patients in whom CAPD catheters were removed</LI>
<LI>Number of patients switching to haemodialysis</LI>
<LI>Number of patients hospitalised and average number of days of hospitalisation</LI>
<LI>Measures of quality of life and patient preference</LI>
<LI>All-cause mortality</LI>
</OL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-11-20 11:50:34 +1100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Renal Group's Specialised Register on 23 October 2013 through contact with the Trials' Search Co-ordinator using search terms relevant to this review.</P>
<P>The Cochrane Renal Group&#8217;s Specialised Register contains studies identified from several sources:</P>
<OL>
<LI>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</LI>
<LI>Weekly searches of MEDLINE OVID SP</LI>
<LI>Handsearching of renal-related journals and the proceedings of major renal conferences</LI>
<LI>Searching of the current year of EMBASE OVID SP</LI>
<LI>Weekly current awareness alerts for selected renal journals</LI>
<LI>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</LI>
</OL>
<P>Details of these strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available in the Specialised Register section of information about the <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html">Cochrane Renal Group</A>. See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for search terms used in strategies for this review.</P>
<P>For search strategies used in our previous review please see <LINK REF="REF-Daly-2000" TYPE="REFERENCE">Daly 2000</LINK>.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-09-29 13:51:28 +1000" MODIFIED_BY="[Empty name]">
<P>The full-text of each relevant identified study were assessed independently by two assessors for subject relevance and methodological quality using a standard form. Details concerning method of random allocation, blinding, description of withdrawals and dropouts, and whether data were analysed on an intention to treat basis were noted.</P>
<SUBSECTION>
<HEADING LEVEL="3">Data abstraction</HEADING>
<P>Data on predetermined outcome measures were abstracted from included studies using a standard form, by a single assessor and data-entry on REVIEW MANAGER 4.2.3 was performed. All data were independently checked from the original papers by a second investigator. A third investigator performed data abstraction and requested additional unpublished or unclear information from the authors of all included trials at the time of updating the present review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Study quality</HEADING>
<P>The quality of included studies was assessed by two independent investigators without blinding to authorship or journal using the checklist developed by the Cochrane Renal Group. Discrepancies were resolved by discussion with a third investigator. The quality items assessed were allocation concealment, blinding of investigators, participants and outcome assessors, intention-to-treat analysis, and the completeness to follow-up.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Quality checklist</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<UL>
<LI>Adequate (A): Randomisation method described that would not allow investigator/participant to know or influence intervention group before eligible participant entered in the study</LI>
<LI>Unclear (B): Randomisation stated but no information on method used is available</LI>
<LI>Inadequate (C): Method of randomisation used such as alternate medical record numbers or unsealed envelopes; any information in the study that indicated that investigators or participants could influence intervention group</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blinding</HEADING>
<UL>
<LI>Blinding of investigators: Yes/no/not stated</LI>
<LI>Blinding of participants: Yes/no/not stated</LI>
<LI>Blinding of outcome assessor: Yes/no/not stated</LI>
<LI>Blinding of data analysis: Yes/no/not stated</LI>
</UL>
<P>The above are considered not blinded if the treatment group can be identified in &gt; 20% of participants because of the side effects of treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intention-to-treat analysis</HEADING>
<UL>
<LI>Yes: Specifically reported by authors that intention-to-treat analysis was undertaken and this was confirmed on study assessment.</LI>
<LI>Yes: not specifically stated but confirmed on study assessment</LI>
<LI>No: Not reported and lack of intention-to-treat analysis confirmed on study assessment (Patients who were randomised were not included in the analysis because they did not receive the study intervention, they withdrew from the study or were not included because of protocol violation).</LI>
<LI>No: Stated, but not confirmed upon study assessment</LI>
<LI>Not stated</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Completeness to follow-up</HEADING>
<P>Percent of participants excluded or lost to follow-up.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Statistical assessment</HEADING>
<P>Data from individual trials were analysed using the risk ratio (RR) measure and its 95% confidence intervals (CI) for dichotomous outcomes and the mean difference (MD) and its 95% CI for continuous outcomes. Subgroup analysis was planned to explore potential sources of variability in observed treatment effect where possible (paediatric versus adult population, diabetic versus non diabetic, trial quality items, timing of peritonitis or other outcome). Heterogeneity of treatment effects between studies was formally tested using the Q (heterogeneity &#967;) and the I statistics. When appropriate, summary estimators of treatment effects were calculated using a random effects model with RR and its 95% CI. Where data on the number of subjects with events (e.g. number of subjects with one or more episodes of peritonitis) were available, the RR was calculated as the ratio of the incidence of the event (one or more episodes) in the experimental treatment group over the incidence in the control group. Where data on the number of episodes were available, then the RR was calculated as the ratio of the rate of the outcome (e.g. the peritonitis rate) in the experimental treatment group (given by number of episodes of the outcome over total patient months on PD) over the rate in the control group. It was also planned that if sufficient RCTs were identified, an attempt would be made to assess for publication bias using a funnel plot (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>).</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-09-23 10:18:55 +1000" MODIFIED_BY="Gail Y Higgins">
<STUDY_DESCRIPTION MODIFIED="2016-09-23 10:18:55 +1000" MODIFIED_BY="Gail Y Higgins">
<P>We identified twelve RCTs comparing double bag, Y-set and standard transfer systems with a total of 991 randomised patients (<LINK REF="STD-Cheng-1994" TYPE="STUDY">Cheng 1994</LINK>; <LINK REF="STD-Churchill-1989" TYPE="STUDY">Churchill 1989</LINK>; <LINK REF="STD-Dryden-1992" TYPE="STUDY">Dryden 1992</LINK>; <LINK REF="STD-Harris-1996" TYPE="STUDY">Harris 1996</LINK>; <LINK REF="STD-Kiernan-1995" TYPE="STUDY">Kiernan 1995</LINK>; <LINK REF="STD-Li-1996" TYPE="STUDY">Li 1996</LINK>; <LINK REF="STD-Li-1999" TYPE="STUDY">Li 1999</LINK>; <LINK REF="STD-Lindholm-1988" TYPE="STUDY">Lindholm 1988</LINK>; <LINK REF="STD-Maiorca-1983" TYPE="STUDY">Maiorca 1983</LINK>; <LINK REF="STD-Monteon-1998" TYPE="STUDY">Monteon 1998</LINK>; <LINK REF="STD-Owen-1992" TYPE="STUDY">Owen 1992</LINK>; <LINK REF="STD-Rottembourg-1987" TYPE="STUDY">Rottembourg 1987</LINK>). One study (<LINK REF="STD-Monteon-1998" TYPE="STUDY">Monteon 1998</LINK>) compared all three system types, seven compared only Y-set with standard systems (<LINK REF="STD-Cheng-1994" TYPE="STUDY">Cheng 1994</LINK>; <LINK REF="STD-Churchill-1989" TYPE="STUDY">Churchill 1989</LINK>; <LINK REF="STD-Li-1996" TYPE="STUDY">Li 1996</LINK>; <LINK REF="STD-Lindholm-1988" TYPE="STUDY">Lindholm 1988</LINK>; <LINK REF="STD-Maiorca-1983" TYPE="STUDY">Maiorca 1983</LINK>; <LINK REF="STD-Owen-1992" TYPE="STUDY">Owen 1992</LINK>; <LINK REF="STD-Rottembourg-1987" TYPE="STUDY">Rottembourg 1987</LINK>), one compared only double bag with standard systems (<LINK REF="STD-Dryden-1992" TYPE="STUDY">Dryden 1992</LINK>) and three compared only double bag with Y-set systems (<LINK REF="STD-Harris-1996" TYPE="STUDY">Harris 1996</LINK>; <LINK REF="STD-Kiernan-1995" TYPE="STUDY">Kiernan 1995</LINK>; <LINK REF="STD-Li-1999" TYPE="STUDY">Li 1999</LINK>). Some of the trials' reports did not include data relevant to all this review's outcomes or reported these data in a manner that precluded inclusion in the meta-analyses (e.g. standard deviations were not available). Of all authors which were contacted for clarification and requests of additional information, only one replied (<LINK REF="STD-Harris-1996" TYPE="STUDY">Harris 1996</LINK>). As a consequence, some of the meta-analyses include fewer studies and fewer patients than might be expected. The publication of the studies were fairly evenly spread over a 16 year period from 1983 (<LINK REF="STD-Maiorca-1983" TYPE="STUDY">Maiorca 1983</LINK>) to 1999 (<LINK REF="STD-Li-1999" TYPE="STUDY">Li 1999</LINK>).</P>
<P>A search performed in January 2005 identified three potential studies which were not relevant to this review (<LINK REF="STD-Huang-2001" TYPE="STUDY">Huang 2001</LINK>; Li 2002; <LINK REF="STD-Ong-2003" TYPE="STUDY">Ong 2003</LINK>). In this 2013 updated review, we excluded six new trials (<LINK REF="STD-Bailie-1990" TYPE="STUDY">Bailie 1990</LINK>; <LINK REF="STD-Burkart-1990" TYPE="STUDY">Burkart 1990</LINK>; <LINK REF="STD-de-Fijter-1994" TYPE="STUDY">de Fijter 1994</LINK>; <LINK REF="STD-Lee-1997" TYPE="STUDY">Lee 1997</LINK>; <LINK REF="STD-Tan-2005" TYPE="STUDY">Tan 2005</LINK>; <LINK REF="STD-Wong-2006" TYPE="STUDY">Wong 2006</LINK>); one is awaiting classification (Correa-Rotter 1997a).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>Details of the methodological quality of the included RCTs are outlined in the description of included studies. Only four studies described the method of randomisation. One described a probably secure method of random allocation (<LINK REF="STD-Monteon-1998" TYPE="STUDY">Monteon 1998</LINK>, central list of random numbers with order of allocation sent to participating centres in sealed envelopes). Two did not completely describe their method of random allocation (<LINK REF="STD-Churchill-1989" TYPE="STUDY">Churchill 1989</LINK>, "variable blocking factor, by the coordinating centre", no other details given; <LINK REF="STD-Maiorca-1983" TYPE="STUDY">Maiorca 1983</LINK>, "closed envelope system", no other details given). <LINK REF="STD-Cheng-1994" TYPE="STUDY">Cheng 1994</LINK> described an unclear method of random allocation (random number tables but "investigators were not blind to what treatment previously recruited patients received", i.e. the next treatment could be anticipated). All twelve had parallel designs. Only two (<LINK REF="STD-Cheng-1994" TYPE="STUDY">Cheng 1994</LINK>; <LINK REF="STD-Lindholm-1988" TYPE="STUDY">Lindholm 1988</LINK>) failed to describe withdrawals and dropouts. None of the study reports clearly stated that data were analysed on an intention to treat basis, although for only four (<LINK REF="STD-Harris-1996" TYPE="STUDY">Harris 1996</LINK>; <LINK REF="STD-Li-1999" TYPE="STUDY">Li 1999</LINK>; <LINK REF="STD-Maiorca-1983" TYPE="STUDY">Maiorca 1983</LINK>; <LINK REF="STD-Monteon-1998" TYPE="STUDY">Monteon 1998</LINK>) was it clear that analysis was not on an intention-to-treat basis. Blinding or masking was infrequently described and none of the studies stated specifically that patients, healthcare providers or outcome assessors were masked/blinded to the intervention.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-01-06 09:58:18 +1100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Y-set versus standard spike systems</HEADING>
<P>The use of the Y-set compared to standard spike systems was associated with a significantly lower risk of peritonitis (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK> (7 trials, 485 patients): RR 0.64, 95% CI 0.53 to 0.77), peritonitis rate (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK> (8 trials, 7417 patient-months): RR 0.49, 95% CI 0.40 to 0.61) but no difference in exit-site/tunnel infection (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK> (3 trials, 226 patients): RR 1.02, 95% CI 0.72 to 1.46) and rate (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK> (2 trials, 2841 patient-months): RR 1.24, 95% CI 0.91 to 1.69).</P>
<P>A number of different definitions of "technique failure" (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>, <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>) reported in the studies were considered in this review including: (i) switch to haemodialysis, (ii) switch to different transfer set and (iii) no longer on allocated treatment for whatever reason. Overall, there was no significant difference in the risk of technique failure with the Y-set compared to standard spike systems with any of these definitions. There was also no difference in the risk of catheter removal (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK> (1 trial, 40 patients): RR 0.33, 95% CI 0.04 to 2.94). Only a single study which compared Y-set with standard systems reported data on all-cause (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK> (1 study, 69 patients): RR 1.12, 95% CI 0.81 to 1.56) and peritonitis-related (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK> (1 study, 69 patients): RR 0.61, 95% CI 0.26 to 1.44) hospitalisation, and showed no significant difference in the risk. There was also no significant difference in the risk of all-cause mortality with the Y-set compared to standard spike systems (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK> (5 trials, 355 patients): RR 1.03, 95% CI 0.48 to 2.21). Heterogeneity was not significant in any of these analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Double bag versus standard systems</HEADING>
<P>There was no statistically significant difference with double bag systems compared to standard systems for the risk of peritonitis (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK> (2 trials, 170 patients): RR 0.43, 95% CI 0.29 to 0.62), the peritonitis rate (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK> (2 trials, 2110 patient-months): RR 0.31, 95% CI 0.20 to 0.47), technique failure (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK> (1 trial, 80 patients): RR 1.00, 95% CI 0.06 to 15.44), exit-site/tunnel infection (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK> (1 trial, 80 patients): RR 0.75, 95% CI 0.18 to 3.14) and all-cause mortality (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK> (1 trial, 80 patients): RR 1.00, 95% CI 0.21 to 4.66) with no significant heterogeneity in any analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Y-set or double bag systems versus standard systems</HEADING>
<P>The combined analysis of Y-set or double bag systems compared to standard systems demonstrated a significant reduction in the risk of peritonitis (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK> (8 trials, 626 patients): RR 0.58, 95% CI 0.49 to 0.68) and peritonitis rate (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK> (11 trials, 10082 patient-months): RR 0.55, 95% CI 0.42 to 0.32) but no significant difference in the risk of exit-site/tunnel infection (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK> (3 trials, 264 patients): RR 1.00, 95% CI 0.71 to 1.42) and rate (<LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK> (2 trials, 2841 patient-months): RR 1.24, 95% CI 0.91 to 1.69), catheter removal (<LINK REF="CMP-003.05" TYPE="ANALYSIS">Analysis 3.5</LINK> (1 trial, 40 patients): RR 0.33, 95% CI 0.04 to 2.94), technique failure by various definitions (<LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK> and <LINK REF="CMP-003.07" TYPE="ANALYSIS">Analysis 3.7</LINK>), the number of patients hospitalised due to any cause (<LINK REF="CMP-003.08" TYPE="ANALYSIS">Analysis 3.8</LINK> (1 trial, 69 patients): RR 1.12, 95% CI 0.81 to 1.56) or number of patients hospitalised due to peritonitis (<LINK REF="CMP-003.09" TYPE="ANALYSIS">Analysis 3.9</LINK> (1 trial, 69 patients): RR 0.61, 95% CI 0.26 to 1.44) and all-cause mortality (<LINK REF="CMP-003.10" TYPE="ANALYSIS">Analysis 3.10</LINK> (6 trials, 435 patients): RR 1.03, 95% CI 0.52 to 2.03). There was significant heterogeneity in the analysis of peritonitis rate (heterogeneity &#967; = 26.78, P = 0.003, I = 62.7%) caused mainly by the trial of <LINK REF="STD-Kiernan-1995" TYPE="STUDY">Kiernan 1995</LINK> which had a shorter follow-up duration compared to all others.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Double bag systems versus Y-set systems</HEADING>
<P>There was no significant difference with double bag compared to Y-set for the risk of peritonitis (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK> (3 trials, 292 patients): RR 0.59, 95% CI 0.35 to 1.01), peritonitis rate (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK> (4 trials, 4319 patients-months): RR 0.90, 95% CI 0.49 to 1.66), exit-site/tunnel infection rate (<LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK> (2 trials, 2319 patient-months): RR 1.04, 95% CI 0.52 to 2.06), technique failure by various definitions (<LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>, <LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>). There was also no difference in catheter removal/replacement (<LINK REF="CMP-004.06" TYPE="ANALYSIS">Analysis 4.6</LINK> (1 trial 63 patients): RR 0.10, 95% CI 0.01 to 1.81) and all-cause mortality (<LINK REF="CMP-004.07" TYPE="ANALYSIS">Analysis 4.7</LINK> (2 trials, 193 patients): RR 0.98 95% CI 0.25 to 3.43). The analysis of peritonitis rate showed significant heterogeneity (heterogeneity &#967; = 12.24, P = 0.007, I = 75.5%) which is imputable to the trial of <LINK REF="STD-Kiernan-1995" TYPE="STUDY">Kiernan 1995</LINK>. This trial had a shorter follow-up duration compared to all others.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Quality of Life</HEADING>
<P>Only two studies reported quality of life data (<LINK REF="STD-Harris-1996" TYPE="STUDY">Harris 1996</LINK>; <LINK REF="STD-Li-1999" TYPE="STUDY">Li 1999</LINK>). Both compared a double bag with a Y-set system. <LINK REF="STD-Harris-1996" TYPE="STUDY">Harris 1996</LINK>, using a Lickert scale, reported significantly greater "ease of use" and <LINK REF="STD-Li-1996" TYPE="STUDY">Li 1996</LINK>, using a 6-item questionnaire, reported significantly greater "patient acceptability" with the double bag system. It was unclear how well-validated these instruments of assessment are in this particular setting.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-11-20 11:47:29 +1100" MODIFIED_BY="[Empty name]">
<P>This systematic review of double bag or Y-set versus standard transfer systems for CAPD has demonstrated that disconnect (double bag and Y-connection) systems are superior to conventional spike (or luer lock) connect systems for the prevention of peritonitis. There was no statistically significant advantage of twin bag systems compared with Y-systems, although the former were associated with a trend towards fewer affected patients with peritonitis (P = 0.05).</P>
<P>To our knowledge, the present study represents the most comprehensive systematic review of the relative benefits and harms of double bag or Y-set systems in PD patients. Two additional reviews have now been published and relate to the use of anti-microbial strategies (<LINK REF="REF-Strippoli-2004a" TYPE="REFERENCE">Strippoli 2004a</LINK>) and other catheter-related interventions including catheter type and surgical techniques for insertion of the PD catheter (<LINK REF="REF-Strippoli-2004b" TYPE="REFERENCE">Strippoli 2004b</LINK>) used to prevent PD peritonitis.</P>
<P>The most likely reason for the observation that disconnect systems are superior to conventional spike systems is a reduction of inadvertent peritoneal microbial contamination during connections with Y-set and twin bag systems as a result of the "flush before fill" manoeuvre (<LINK REF="REF-Bazzato-1980" TYPE="REFERENCE">Bazzato 1980</LINK>). Although the elimination of one connection procedure by twin bag systems should theoretically further reduce peritonitis episodes beyond that achieved by Y-connection systems, this was unable to be demonstrated in our study. In contrast in a previous version of this review (<LINK REF="REF-Daly-2000" TYPE="REFERENCE">Daly 2000</LINK>) we reported a significantly lower risk of experiencing peritonitis episodes with double bag systems compared with Y-systems (odds ratio 0.44, 95% CI 0.27 to 0.71). This apparent disparity may be partly explained by the more conservative statistical approach adopted in the present analysis (random effects model) compared with the previous (fixed effects model). In order to better assess the robustness of our statistical findings, we also additionally evaluated peritonitis rates as episodes/month (rather than just number of patients experiencing peritonitis) and again demonstrated no statistically significant differences between the two disconnect systems. Similar findings were observed for the other outcome measures evaluated, including exit-site/tunnel infections, catheter removal, technique survival and all-cause mortality.</P>
<P>These results support the recommendations of the British Renal Association (BRA) and the Caring for Australians with Renal Impairment (CARI) guidelines against the use of conventional spike connection systems. Although the International Society of Peritoneal Dialysis and K/DOQI clinical practice guidelines make no specific recommendations about connection methodology, spike and luer lock connect system usage has generally been declining in recent years. In the United Kingdom, the use of connect PD systems has decreased from 22% in 1998 to less than 1% in 2002 (<LINK REF="REF-Ansell-1998" TYPE="REFERENCE">Ansell 1998</LINK>). A similar experience has been reported in Australia and New Zealand (<LINK REF="REF-Johnson-2003" TYPE="REFERENCE">Johnson 2003</LINK>).</P>
<P>The strength of this investigation is that it represents a comprehensive systematic review based on a previous publication of a detailed protocol, rigid inclusion criteria for RCTs only, and a comprehensive multi-database literature search. Data extraction, data analysis and method quality assessment were performed by two independent investigators, and consistency was checked with an additional reviewer. Furthermore, infectious outcomes were separately examined in terms of rates per patient-month (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>; <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>) and the number of patients affected in order to maximise statistical power and to verify the robustness of statistical analyses.</P>
<P>The main weakness of this study was the relative paucity of quality RCTs identified. The vast majority of studies evaluated failed to specify whether randomisation allocation was concealed, outcome assessors were blinded or data were analysed on an intention to treat basis. Many studies were small and often short in duration, so that the possibility of a type 2 statistical error for some of the less frequently observed outcome measures (e.g. catheter loss) could not be excluded. Moreover, evidence of trial heterogeneity was found in some analyses of peritonitis rates (twin bag versus Y-set), which most likely reflected significant inter-trial variation in durations of follow-up. These issues reduce the strength of the conclusions that have been drawn in this review.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Disconnect (twin bag and Y-set) systems are superior to conventional spike systems with respect to the prevention of peritonitis. No clear advantage of twin bag over Y-set systems could be shown, although available trials were limited. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Peritonitis is the most frequent serious complication of CAPD. It is essential that innovations in CAPD technique or technology designed to reduce peritonitis rates are subject to rigorous assessment by well-designed RCTs. This review demonstrates that the above interventions have been very poorly studied to date. There is an obvious need in this area for well-designed, RCTs (with clear descriptions of trial methodologies). The double bag and Y-set systems should be the standard against which future design modifications in CAPD transfer technology are compared. If more than one intervention is being considered clinical trials should be designed to identify clearly to which intervention beneficial or adverse effects can be attributed. There is likely to be no additional research benefit in further trials comparing double bag, Y-set and standard CAPD exchange systems.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-12-18 13:43:20 +1100" MODIFIED_BY="[Empty name]">
<P>This review was funded by the NHS Executive Research and Development Health Technology Assessment Programme. The Health Services Research Unit and the Health Economics Research Unit are funded by the Chief Scientist's Office, Scottish Executive Health Department. The authors would like to thank Carol Ritchie and Gloria Montague for secretarial support.</P>
<P>We also wish to gratefully acknowledge the contributions of Marion Campbell, Alison MacLeod, Adrian Grant and Paul Lawrence to earlier versions of this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-12-18 13:46:21 +1100" MODIFIED_BY="[Empty name]">
<P>Sheila Wallace is a Trials Search Co-ordinator for the Cochrane Incontinence Review Group, whose single largest funder is the UK National Institute for Health Research (NIHR). The exploratory meeting to set up the Cochrane Incontinence Review Group was funded by Zeneca Pharmaceuticals in 1995. </P>
<P>Following completion of this review, an unrestricted educational grant from Janssen Cilag funded a further six systematic reviews related to ESKD and erythropoietin.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-09-29 11:57:09 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Study conception (including funding): MacLeod A, Grant A , Daly C, Donaldson C, Campbell M, Khan I, Lawrence P</LI>
<LI>Protocol development: Campbell M, Cody J, Daly C, Donaldson C, Grant A, Vale L, Lawrence P, MacLeod A, Wallace S, Khan I</LI>
<LI>Literature search: Wallace S, Daly C, Lawrence P, Cody J, Khan I, Vale L, MacLeod A</LI>
<LI>Data extraction and analysis: Daly C, Campbell M, Khan I, Cody J</LI>
<LI>Writing of draft report: Daly C</LI>
<LI>Updating the review: Strippoli GFM (2004)</LI>
<LI>Editorial role and agreement of final manuscript: Campbell M, Cody J, Daly C, Donaldson C, Grant A, Vale L, Lawrence P, MacLeod A, Wallace S, Khan I</LI>
</UL>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2016-09-22 16:45:30 +1000" MODIFIED_BY="Narelle S Willis">
<P>There have been no new or ongoing studies since 1999, therefore this review is no longer being updated. Correa-Rotter 1997, listed as awaiting assessment has now been excluded.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-09-26 01:33:36 +0100" MODIFIED_BY="Narelle Willis">
<STUDIES MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis">
<INCLUDED_STUDIES MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis">
<STUDY DATA_SOURCE="PUB" ID="STD-Cheng-1994" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Cheng 1994" YEAR="1994">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheng IK, Chan CY, Cheng SW, Poon JF, Ji YL, Lo WK, et al</AU>
<TI>A randomized prospective study of the cost-effectiveness of the conventional spike, O-set, and UVXD techniques in continuous ambulatory peritoneal dialysis</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1994</YR>
<VL>14</VL>
<NO>3</NO>
<PG>255-60</PG>
<IDENTIFIERS MODIFIED="2008-09-29 13:42:53 +1000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909221"/><IDENTIFIER MODIFIED="2008-09-29 13:42:53 +1000" MODIFIED_BY="[Empty name]" TYPE="EMBASE" VALUE="1994264793"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909220"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Churchill-1989" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Churchill 1989" YEAR="1989">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Churchill DN, Canadian CAPD Clinical Trials Group</AU>
<TI>Randomised clinical trial comparing peritonitis rates among new CAPD patients using the Y set disinfectant system to standard systems [abstract]</TI>
<SO>Kidney International</SO>
<YR>1989</YR>
<VL>35</VL>
<NO>1</NO>
<PG>268</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909223"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Churchill DN, Taylor DW, Vas SI, Singer J, Beecroft ML, Wu G, et al</AU>
<TI>Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Canadian CAPD Clinical Trials Group</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1989</YR>
<VL>9</VL>
<NO>3</NO>
<PG>159-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909224"/><IDENTIFIER TYPE="MEDLINE" VALUE="2488361"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909222"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dryden-1992" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Dryden 1992" YEAR="1992">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dryden MS, McCann M, Wing AJ, Phillips I</AU>
<TI>Controlled trial of a Y-set dialysis delivery system to prevent peritonitis in patients receiving continuous ambulatory peritoneal dialysis</TI>
<SO>Journal of Hospital Infection</SO>
<YR>1992</YR>
<VL>20</VL>
<NO>3</NO>
<PG>185-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909226"/><IDENTIFIER TYPE="MEDLINE" VALUE="1348773"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909225"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harris-1996" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Harris 1996" YEAR="1996">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harris DC, Yuill EJ, Byth K, Chapman JR, Hunt C</AU>
<TI>Twin- versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis</TI>
<SO>Journal of the Amercian Society of Nephrology</SO>
<YR>1996</YR>
<VL>7</VL>
<NO>11</NO>
<PG>2392-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909228"/><IDENTIFIER TYPE="MEDLINE" VALUE="8959630"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909227"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kiernan-1995" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Kiernan 1995" YEAR="1995">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, et al</AU>
<TI>Comparison of continuous ambulatory peritoneal dialysis-related infections with different &#8220;Y-tubing&#8221; exchange systems</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1995</YR>
<VL>5</VL>
<NO>10</NO>
<PG>1835-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909230"/><IDENTIFIER TYPE="MEDLINE" VALUE="7787152"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909229"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-1996" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Li 1996" YEAR="1996">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Li PK, Chan TH, So WY, Wang AYM, Leung CB, Lai KN</AU>
<TI>Comparisons of Y-set disconnect system (Ultraset) versus conventional spike system in uremic patients on CAPD: outcome and cost analysis</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1996</YR>
<VL>16</VL>
<NO>Suppl 1</NO>
<PG>S368-S70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909232"/><IDENTIFIER TYPE="MEDLINE" VALUE="8728225"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909231"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-1999" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Li 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li PK, Law MC, Chan WK, Szeto CC, Chen YL, Lui SF, et al</AU>
<TI>Comparison of two double-bag systems in continuous ambulatory peritoneal dialysis - a prospective randomised controlled multi-center study [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>Program &amp; Abstracts</NO>
<PG>312a</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909234"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li PK, Law MC, Chow KM, Chan WK, Szeto CC, Cheng YL, et al</AU>
<TI>Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis - a prospective randomized controlled multi-center study [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>2002</YR>
<VL>13</VL>
<NO>Program &amp; Abstracts</NO>
<PG>43a</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909235"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-11-20 11:59:13 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li PK, Law MC, Chow KM, Chan WK, Szeto CC, Cheng YL, et al</AU>
<TI>Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, controlled, multicenter study</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>2002</YR>
<VL>40</VL>
<NO>2</NO>
<PG>373-80</PG>
<IDENTIFIERS MODIFIED="2008-09-29 13:43:14 +1000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909236"/><IDENTIFIER MODIFIED="2008-09-29 13:43:12 +1000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="22141952"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Li PK, Szeto CC, Law MC, Chau KF, Fung KS, Leung CB, et al</AU>
<TI>Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>1999</YR>
<VL>33</VL>
<NO>3</NO>
<PG>535-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909237"/><IDENTIFIER TYPE="MEDLINE" VALUE="10070918"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909233"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindholm-1988" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Lindholm 1988" YEAR="1988">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lindholm T, Simonsen O, Krutzen L, van Leusen R, Jordans JG, Moyy JM, et al</AU>
<TI>Evaluation of a new take-off system: a prospective randomized multicenter study</TI>
<SO>Advances in Peritoneal Dialysis</SO>
<YR>1988</YR>
<VL>4</VL>
<PG>264-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909239"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909238"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maiorca-1983" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Maiorca 1983" YEAR="1983">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, et al</AU>
<TI>Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis</TI>
<SO>Lancet</SO>
<YR>1983</YR>
<VL>2</VL>
<NO>8351</NO>
<PG>642-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909241"/><IDENTIFIER TYPE="MEDLINE" VALUE="6136794"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Strada A, Graziani G, et al</AU>
<TI>'Y' connector system for prevention of peritonitis in CAPD: a controlled study</TI>
<SO>Proceedings of the European Dialysis &amp; Transplant Association</SO>
<YR>1983</YR>
<VL>20</VL>
<PG>223-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909242"/><IDENTIFIER TYPE="MEDLINE" VALUE="6361737"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909240"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Monteon-1998" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Monteon 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Monteon F, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, et al</AU>
<TI>Prevention of peritonitis with disconnect systems in CAPD: A randomized controlled trial</TI>
<SO>Kidney International</SO>
<YR>1998</YR>
<VL>54</VL>
<NO>6</NO>
<PG>2123-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909244"/><IDENTIFIER TYPE="MEDLINE" VALUE="9853278"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909243"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Owen-1992" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Owen 1992" YEAR="1992">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Owen JE, Walker RG, Lemon J, Brett L, Mitrou D, Becker GJ</AU>
<TI>Randomized study of peritonitis with conventional versus O-set techniques in continuous ambulatory peritoneal dialysis</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1992</YR>
<VL>12</VL>
<NO>2</NO>
<PG>216-20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909246"/><IDENTIFIER TYPE="MEDLINE" VALUE="1586684"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909245"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rottembourg-1987" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Rottembourg 1987" YEAR="1987">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rottembourg J, Brouard R, Issad I, Allouache M, Jacobs C</AU>
<TI>Prospective randomised study about Y connectors in CAPD patients</TI>
<SO>Advances in Peritoneal Dialysis</SO>
<YR>1987</YR>
<PG>107-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909248"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rottembourg J, Brouard R, Issad I, Allouache M, Nguyen J, Montassine MC, et al</AU>
<TI>Prevention of peritonitis during continuous ambulatory peritoneal dialysis. Value of disconnectable systems</TI>
<TO>Prevention des peritonites au cours de la dialyse peritoneale continue ambulatoire. Interet des systemes deconnectables</TO>
<SO>Presse Medicale</SO>
<YR>1988</YR>
<VL>17</VL>
<NO>26</NO>
<PG>1349-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909249"/><IDENTIFIER TYPE="MEDLINE" VALUE="2970080"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909247"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis">
<STUDY DATA_SOURCE="PUB" ID="STD-Amato-1999" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Amato 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amato D, Paniagua R</AU>
<TI>Comparison of double-bag and Y-set disconnect systems in CAPD</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>1999</YR>
<VL>34</VL>
<NO>2</NO>
<PG>402-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909251"/><IDENTIFIER TYPE="MEDLINE" VALUE="10465729"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909250"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bailie-1990" MODIFIED="2013-11-20 11:15:49 +1100" MODIFIED_BY="[Empty name]" NAME="Bailie 1990" YEAR="1990 May">
<REFERENCE MODIFIED="2013-11-20 11:15:49 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bailie GR, Rasmussen R, Hollister A, Eisele G</AU>
<TI>Incidence of CAPD peritonitis in patients using UVXD or O-set systems</TI>
<SO>Clinical Nephrology</SO>
<YR>1990</YR>
<VL>33</VL>
<NO>5</NO>
<PG>252-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909253"/><IDENTIFIER TYPE="MEDLINE" VALUE="2354562"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909252"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Balteau-1991" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Balteau 1991" YEAR="991">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Balteau P, Peluso FP, Coles GA, Michel C, Mignon FM, Tranaeus AP, et al</AU>
<TI>Design and testing of the Baxter Integrated Disconnect Systems</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1991</YR>
<VL>11</VL>
<NO>2</NO>
<PG>131-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909255"/><IDENTIFIER TYPE="MEDLINE" VALUE="1854869"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909254"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buoncristiani-1989" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Buoncristiani 1989" YEAR="1989">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buoncristani U</AU>
<TI>The Y-set with disinfectant is here to stay</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1989</YR>
<VL>9</VL>
<NO>3</NO>
<PG>149-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909257"/><IDENTIFIER TYPE="MEDLINE" VALUE="2488358"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909256"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burkart-1990" MODIFIED="2013-11-20 11:16:03 +1100" MODIFIED_BY="[Empty name]" NAME="Burkart 1990" YEAR="1990">
<REFERENCE MODIFIED="2013-11-20 11:16:03 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burkart JM, Hylander B, Durnell-Figel T, Roberts D</AU>
<TI>Comparison of peritonitis rates during long-term use of standard spike versus Ultraset in continuous ambulatory peritoneal dialysis (CAPD)</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1990</YR>
<VL>10</VL>
<NO>1</NO>
<PG>41-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909259"/><IDENTIFIER TYPE="MEDLINE" VALUE="2085581"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909258"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cancarini-1995" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Cancarini 1995" YEAR="1995">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cancarini G, Catizone L, Fellini G, Feriani M, Quarello F, The Italian Study Group on CAPD connecting systems</AU>
<TI>Peritonitis prevention in CAPD. A flushing vs flushing + in line disinfectant comparison</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1995</YR>
<VL>15</VL>
<NO>Suppl 4</NO>
<PG>51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909261"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909260"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Correa_x002d_Rotter-1997" MODIFIED="2016-09-22 16:35:11 +1000" MODIFIED_BY="Narelle S Willis" NAME="Correa-Rotter 1997" YEAR="1997">
<REFERENCE MODIFIED="2016-09-22 16:35:11 +1000" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Correa-Rotter R, Monteon FJ, Paniagua R, Amato D, Moran JE</AU>
<TI>Peritonitis prevention with disconnect systems in CAPD: a prospective, randomized, controlled, multi-center clinical trial [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1997</YR>
<VL>8</VL>
<NO>Program &amp; Abstracts</NO>
<PG>262A</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909317"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909316"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Fijter-1994" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="de Fijter 1994" YEAR="1991">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Fijter CW, Oe LP, Nauta JJ, van der Meulen J, Verbrugh HA, Verhoef J, et al</AU>
<TI>Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1994</YR>
<VL>120</VL>
<NO>4</NO>
<PG>264-71</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909263"/><IDENTIFIER TYPE="MEDLINE" VALUE="8291819"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-11-20 12:07:02 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Fijter CW, Oe LP, van der Meulen J, Nauta JJ, Donker AJ</AU>
<TI>Outcome in continuous ambulatory peritoneal dialysis with y-set (CAPD-Y) versus continuous cyclic peritoneal dialysis (CCPD): a prospective, randomized comparison [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1992</YR>
<VL>3</VL>
<NO>3</NO>
<PG>408</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909264"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Fijter CW, Oe PL, Nauta JJ, van der Meulen J, ter Wee PM, Snoek FJ, et al</AU>
<TI>A prospective, randomized study comparing the peritonitis incidence of CAPD and Y-connector (CAPD-Y) with continuous cyclic peritoneal dialysis (CCPD)</TI>
<SO>Advances in Peritoneal Dialysis</SO>
<YR>1991</YR>
<VL>7</VL>
<PG>186-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909265"/><IDENTIFIER TYPE="MEDLINE" VALUE="1680422"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Fijter CW, Oe PL, Verbrugh HA, Nauta JJ, van der Meulen J, Verhoef J, et al</AU>
<TI>Continuous cyclic peritoneal dialysis: clinical efficacy and comparison with continuous ambulatory peritoneal dialysis</TI>
<SO>Nederlands Tijdschrift Voor Geneeskunde</SO>
<YR>1995</YR>
<VL>139</VL>
<NO>13</NO>
<PG>658-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909266"/><IDENTIFIER TYPE="EMBASE" VALUE="1995102998"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Fijter CW, Oe PL, van der Nauta JJ, van der Meulen J, ter Wee PM, Snoek FJ, et al</AU>
<TI>Peritoneal dialysis-related peritonitis: A prospective, randomized comparison between continuous ambulatory PD with Y-connector (CAPD-Y) and continuous cyclic PD (CCPD) [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1992</YR>
<VL>7</VL>
<NO>2</NO>
<PG>166-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909267"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Fijter CW, Snoek FJ, Oe PL, van der Meulen L, Nauta JJ, Verbrugh HA, et al</AU>
<TI>Has continuous cyclic peritoneal dialysis surplus value over CAPD-Y regarding clinical outcome? [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1993</YR>
<VL>8</VL>
<NO>9</NO>
<PG>1020</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909268"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909262"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Durand-1995" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Durand 1995" YEAR="1995">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Durand PY, Chanliau J, Gamberoni J, Kessler M</AU>
<TI>Connectology for treatment by peritoneal dialysis for chronic renal insufficiency</TI>
<TO>La connectologie pour le traitement par dialyse peritoneale de l&#8217;insuffisance renale chronique</TO>
<SO>Nephrologie</SO>
<YR>1995</YR>
<VL>16</VL>
<NO>1</NO>
<PG>37-44</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909270"/><IDENTIFIER TYPE="MEDLINE" VALUE="7700419"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909269"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia_x002d_Lopez-1994" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Garcia-Lopez 1994" YEAR="1994">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia-Lopez E, Mendoza-Guevara A, Morales A, Aguilar-Kitzu A, Vincenio LM, Hernandez-Fernandez M, et al</AU>
<TI>Comparison of peritonitis rates in children on CAPD with spike connector versus two disconnect systems</TI>
<SO>Advances in Peritoneal Dialysis</SO>
<YR>1994</YR>
<VL>10</VL>
<PG>300-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909272"/><IDENTIFIER TYPE="MEDLINE" VALUE="7999852"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909271"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hall-1989" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Hall 1989" YEAR="1989">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall LJ, Kinney RA, Taber TE, Hegeman TF</AU>
<TI>Comparison of two non-disconnect CAPD delivery systems</TI>
<SO>Advances in Peritoneal Dialysis</SO>
<YR>1989</YR>
<VL>5</VL>
<PG>227-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909274"/><IDENTIFIER TYPE="MEDLINE" VALUE="2577418"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909273"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holley-1994" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Holley 1994" YEAR="1994">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holley JL, Bernardini J, Piraino B</AU>
<TI>Infecting organisms in Continuous Ambulatory Peritoneal Dialysis patients on the Y-set</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>1994</YR>
<VL>23</VL>
<NO>4</NO>
<PG>569-73</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909276"/><IDENTIFIER TYPE="MEDLINE" VALUE="8154494"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909275"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2001" NAME="Huang 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang JW, Hung KY, Yen CJ, Wu KD, Tsai TJ</AU>
<TI>Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>3</NO>
<PG>604-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909278"/><IDENTIFIER TYPE="MEDLINE" VALUE="11239039"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909277"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Junor-1989" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Junor 1989" YEAR="1989">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Junor BJ</AU>
<TI>CAPD disconnect systems</TI>
<SO>Blood Purification</SO>
<YR>1989</YR>
<VL>7</VL>
<NO>2-3</NO>
<PG>156-66</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909280"/><IDENTIFIER TYPE="MEDLINE" VALUE="2663035"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909279"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-1997" MODIFIED="2009-01-08 08:57:42 +1100" MODIFIED_BY="Narelle S Willis" NAME="Lee 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-01-08 08:57:42 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee CC, Tsai CJ, Hong JJ</AU>
<TI>Twinbag disconnect system in continuous ambulatory peritoneal dialysis patients [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1997</YR>
<VL>12</VL>
<NO>9</NO>
<PG>A183</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909282"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909281"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lempert-1986" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Lempert 1986" YEAR="1986">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lempert KD, Kolb JA, Swartz RD, Campese V, Golper TA, Winchester JF, et al</AU>
<TI>Multicenter trial to evaluate the use of the CAPD "O" set</TI>
<SO>ASAIO Transactions</SO>
<YR>1986</YR>
<VL>32</VL>
<NO>1</NO>
<PG>557-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909284"/><IDENTIFIER TYPE="MEDLINE" VALUE="3778768"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909283"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ong-2003" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Ong 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ong LM, Lim TO, Hooi LS, Morad Z, Tan PC, Wong HS, et al</AU>
<TI>A randomized, multicenter, open-label trial to establish therapeutic equivalence between the Carex and Ultra disconnect systems in patients on continuous ambulatory peritoneal dialysis</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>Suppl 2</NO>
<PG>S139-S43</PG>
<IDENTIFIERS MODIFIED="2008-09-29 13:43:42 +1000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909290"/><IDENTIFIER MODIFIED="2008-09-29 13:43:42 +1000" MODIFIED_BY="[Empty name]" TYPE="EMBASE" VALUE="2004037352"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909289"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Orange-1987" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Orange 1987" YEAR="1987">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Orange GV, Henderson IS, Marshall EA</AU>
<TI>Effectiveness of the flush technique in CAPD disconnect systems</TI>
<SO>International Journal of Artificial Organs</SO>
<YR>1987</YR>
<VL>10</VL>
<NO>3</NO>
<PG>185-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909292"/><IDENTIFIER TYPE="MEDLINE" VALUE="3610370"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909291"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Piraino-1993" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Piraino 1993" YEAR="1993">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Piraino B, Holley JL, Bernardini J</AU>
<TI>Are exit-site infection rates lower with disconnect systems</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1993</YR>
<VL>13</VL>
<NO>1</NO>
<PG>67-76</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909294"/><IDENTIFIER TYPE="MEDLINE" VALUE="8443284"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909293"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Port-1992" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Port 1992" YEAR="1992">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA</AU>
<TI>Risk of peritonitis and technique failure by CAPD connection technique: a national study</TI>
<SO>Kidney International</SO>
<YR>1992</YR>
<VL>42</VL>
<NO>4</NO>
<PG>967-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909296"/><IDENTIFIER TYPE="MEDLINE" VALUE="1453589"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909295"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ryckelynck-1988" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Ryckelynck 1988" YEAR="1988">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ryckelynck JP, Verger C, Cam G, Faller B, Pierre D</AU>
<TI>Importance of the flush effect in disconnect systems</TI>
<SO>Advances in Peritoneal Dialysis</SO>
<YR>1988</YR>
<VL>4</VL>
<NO>6</NO>
<PG>282-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909298"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-11-20 12:17:40 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Verger C, Faller B, Ryckelynck JPH, Cam G, Pierre D</AU>
<TI>Efficacy of continuous ambulatory peritoneal dialysis y-line systems without disinfectant and standard systems on peritonitis prevention: a multicentre prospective controlled trial [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1987</YR>
<VL>2</VL>
<NO>5</NO>
<PG>455-6</PG>
<IDENTIFIERS MODIFIED="2013-11-20 12:17:40 +1100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909299"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909297"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-1997" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Smith 1997" YEAR="1997">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith CA</AU>
<TI>Does flush before fill decrease the incidence of peritonitis in our cycler population?</TI>
<SO>Journal CANNT</SO>
<YR>1997</YR>
<VL>7</VL>
<NO>2</NO>
<PG>20-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909301"/><IDENTIFIER TYPE="MEDLINE" VALUE="9281953"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909300"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-1997a" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Smith 1997a" YEAR="1997">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith CA</AU>
<TI>Reduced incidence of peritonitis by utilizing "flush before fill" in APD</TI>
<SO>Advances in Peritoneal Dialysis</SO>
<YR>1997</YR>
<VL>13</VL>
<PG>225-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909303"/><IDENTIFIER TYPE="MEDLINE" VALUE="9360687"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909302"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tan-2005" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Tan 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tan SH, Huang XH, Chan YH, Lim S, Liew AS, Ng TG, et al</AU>
<TI>A prospective comparison of peritonitis between two disconnect CAPD systems in a single centre [abstract]</TI>
<SO>Nephrology</SO>
<YR>2005</YR>
<VL>10</VL>
<NO>Suppl</NO>
<PG>A69-A70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909305"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909304"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tielens-1993" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Tielens 1993" YEAR="1993">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tielens E, Nube MJ, de Vet JA, van Limbeek J, Hofman X, Steffens A, et al</AU>
<TI>Major reduction of CAPD peritonitis after the introduction of the twin-bag system</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1993</YR>
<VL>8</VL>
<NO>11</NO>
<PG>1237-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909307"/><IDENTIFIER TYPE="MEDLINE" VALUE="8302463"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909306"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Viglino-1989" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Viglino 1989" YEAR="1989">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Viglino G, Colombo A, Scalamogna A, Cavalli PL, Guerra L, Renzetti G, et al</AU>
<TI>Prospected randomized study of two Y devices in continuous ambulatory peritoneal dialysis (CAPD)</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1989</YR>
<VL>9</VL>
<NO>3</NO>
<PG>165-168</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909309"/><IDENTIFIER TYPE="MEDLINE" VALUE="2562200"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909308"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Viglino-1993" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Viglino 1993" YEAR="1993">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Viglino G, Colombo A, Cantu P, Camerini C, Catione L, Bonello F, et al</AU>
<TI>In vitro and in vivo efficacy of a new connector device for continuous ambulatory peritoneal dialysis</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1993</YR>
<VL>13</VL>
<NO>Suppl 2</NO>
<PG>S148-S51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909311"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909310"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wong-2006" MODIFIED="2013-11-20 12:19:55 +1100" MODIFIED_BY="[Empty name]" NAME="Wong 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-11-20 12:19:55 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wong HS, Ong LM, Lim TO, Hooi LS, Morad Z, Ghazalli R, et al</AU>
<TI>A randomized, multicenter, open-label trial to determine peritonitis rate, product defect, and technique survival between ANDY-Disc and UltraBag in patients on CAPD</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>2006</YR>
<VL>48</VL>
<NO>3</NO>
<PG>464-72</PG>
<IDENTIFIERS MODIFIED="2013-11-20 12:19:55 +1100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909313"/><IDENTIFIER MODIFIED="2013-11-20 12:19:55 +1100" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="16931220"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909312"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wust-1985" MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" NAME="Wust 1985" YEAR="1985">
<REFERENCE MODIFIED="2016-09-26 10:31:18 +1000" MODIFIED_BY="Narelle Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wust J, Binswanger U, Bichsel G</AU>
<TI>Prevention of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) by Y-connected double bag systems</TI>
<SO>Life Support Systems</SO>
<YR>1985</YR>
<VL>3 Suppl 1</VL>
<PG>107-11</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2909315"/><IDENTIFIER TYPE="MEDLINE" VALUE="3870548"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2909314"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2016-09-22 16:35:11 +1000" MODIFIED_BY="Narelle S Willis"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-11-20 12:27:36 +1100" MODIFIED_BY="Narelle S Willis">
<ADDITIONAL_REFERENCES MODIFIED="2013-11-20 12:27:36 +1100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Ansell-1998" NAME="Ansell 1998" TYPE="OTHER">
<AU>Ansell D, Feest T</AU>
<TI>UK Renal Registry Report 2002</TI>
<SO>http://www.renalreg.com/Downloads.html</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bazzato-1980" NAME="Bazzato 1980" TYPE="JOURNAL_ARTICLE">
<AU>Bazzato G, Landini S, Coli U, Lucatello S, Fracasso A, Maoracchiello M</AU>
<TI>A new technique of continuous ambulatory peritoneal dialysis (CAPD): double-bag system for freedom to the patient and significant reduction of peritonitis</TI>
<SO>Clinical Nephrology</SO>
<YR>1980</YR>
<VL>13</VL>
<NO>6</NO>
<PG>251-4</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="7408242"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Buoncristiani-1980" NAME="Buoncristiani 1980" TYPE="JOURNAL_ARTICLE">
<AU>Buoncristiani U, Cozzari M, Carobi C, Quintaliani G, Barbarossa D, Di Paolo N</AU>
<TI>Semicontinuous semiambulatory peritoneal dialysis</TI>
<SO>Proceedings of the European Dialysis &amp; Transplant Association</SO>
<YR>1980</YR>
<VL>17</VL>
<PG>328-32</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="7243786"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Buoncristiani-1983" NAME="Buoncristiani 1983" TYPE="JOURNAL_ARTICLE">
<AU>Buoncristiani U, Di Paolo N</AU>
<TI>Autosterilizing CAPD connection systems</TI>
<SO>Nephron</SO>
<YR>1983</YR>
<VL>35</VL>
<NO>4</NO>
<PG>244-7</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="6646297"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Buoncristiani-1993" MODIFIED="2008-09-29 13:43:59 +1000" MODIFIED_BY="[Empty name]" NAME="Buoncristiani 1993" TYPE="JOURNAL_ARTICLE">
<AU>Buoncristiani U</AU>
<TI>Continuous ambulatory peritoneal dialysis connection systems</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>1993</YR>
<VL>13 Suppl</VL>
<NO>2</NO>
<PG>139-45</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="8399550"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Buoncristiani-1996" MODIFIED="2008-09-29 13:44:04 +1000" MODIFIED_BY="[Empty name]" NAME="Buoncristiani 1996" TYPE="JOURNAL_ARTICLE">
<AU>Buoncristiani U</AU>
<TI>Birth and evolution of the &#8220;Y&#8221; set</TI>
<SO>ASAIO Journal</SO>
<YR>1996</YR>
<VL>42</VL>
<NO>1</NO>
<PG>8-11</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="8808449"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-CANUSA-1996" NAME="CANUSA 1996" TYPE="JOURNAL_ARTICLE">
<AU>Anonymous</AU>
<TI>Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1996</YR>
<VL>7</VL>
<NO>2</NO>
<PG>198-207</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="8785388"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Churchill-1991" MODIFIED="2008-09-29 13:44:09 +1000" MODIFIED_BY="[Empty name]" NAME="Churchill 1991" TYPE="JOURNAL_ARTICLE">
<AU>Churchill DN</AU>
<TI>CAPD peritonitis: a critical appraisal of prophylactic strategies</TI>
<SO>Seminars in Dialysis</SO>
<YR>1991</YR>
<VL>4</VL>
<NO>2</NO>
<PG>94-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2008-09-29 13:44:15 +1000" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey-Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>109</NO>
<PG>629-34</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="9310563"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Golper-1996" MODIFIED="2008-09-29 13:44:19 +1000" MODIFIED_BY="[Empty name]" NAME="Golper 1996" TYPE="JOURNAL_ARTICLE">
<AU>Golper TA, Brier ME, Bunke M, Schreiber MJ, Bartlett DK, Hamilton RW et al</AU>
<TI>Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>1996</YR>
<VL>28</VL>
<NO>3</NO>
<PG>428-36</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="8804243"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2003" NAME="Johnson 2003" TYPE="BOOK_SECTION">
<AU>Johnson DW</AU>
<TI>Peritoneal Dialysis</TI>
<SO>ANZDATA Registry Report 2003</SO>
<YR>2003</YR>
<PG>39-59</PG>
<ED>McDonald SP, Russ GF</ED>
<PB>Australia and New Zealand Dialysis and Transplantation Registry</PB>
<CY>Adelaide</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nolph-1985" NAME="Nolph 1985" TYPE="JOURNAL_ARTICLE">
<AU>Nolph KD, Prowant B, Serkes KD et al</AU>
<TI>A randomized multicenter clinical trial to evaluate the effects of ultraviolet germicidal system on peritonitis rate in continuous ambulatory peritoneal dialysis</TI>
<SO>Peritoneal Dialysis Bulletin</SO>
<YR>1985</YR>
<VL>5</VL>
<NO>1</NO>
<PG>19-24</PG>
<IDENTIFIERS><IDENTIFIER TYPE="OTHER" VALUE="1985093789"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Popovich-1976" MODIFIED="2013-11-20 12:27:36 +1100" MODIFIED_BY="[Empty name]" NAME="Popovich 1976" TYPE="JOURNAL_ARTICLE">
<AU>Popovich RP, Moncrief JW, Decherd JF, Bonar JB, Pyle WK</AU>
<TI>The definition of a novel/wearable equilibrium peritoneal dialysis technique (Abstract)</TI>
<SO>American Society of Artificial Internal Organs</SO>
<YR>1976</YR>
<VL>5</VL>
<PG>64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Slingeneyer-1983" NAME="Slingeneyer 1983" TYPE="JOURNAL_ARTICLE">
<AU>Slingeneyer A, Mion C</AU>
<TI>Peritonitis prevention in continuous ambulatory peritoneal dialysis: long term efficacy of a bacteriological filter</TI>
<SO>Proceedings of the European Dialysis &amp; Transplant Association</SO>
<YR>1983</YR>
<VL>19</VL>
<PG>388-96</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="6878253"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Strippoli-2004a" MODIFIED="2008-09-29 13:46:05 +1000" MODIFIED_BY="[Empty name]" NAME="Strippoli 2004a" TYPE="COCHRANE_REVIEW">
<AU>Strippoli GFM, Tong A, Johnson D, Schena FP, Craig JC</AU>
<TI>Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2008-09-29 13:46:03 +1000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-09-29 13:46:03 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004679.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Strippoli-2004b" MODIFIED="2013-11-20 11:42:58 +1100" MODIFIED_BY="[Empty name]" NAME="Strippoli 2004b" TYPE="COCHRANE_REVIEW">
<AU>Strippoli GFM, Tong A, Johnson D, Schena FP, Craig JC</AU>
<TI>Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-11-20 11:42:58 +1100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2013-11-20 11:42:58 +1100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004680.pub2"/></IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-11-20 11:47:29 +1100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Daly-2000" MODIFIED="2013-11-20 11:47:29 +1100" MODIFIED_BY="[Empty name]" NAME="Daly 2000" TYPE="COCHRANE_REVIEW">
<AU>Daly C, Campbell M, Cody J, Grant A, Donaldson C, Vale L et al</AU>
<TI>Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2008-09-29 13:48:37 +1000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-09-29 13:48:37 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003078"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2013-10-17 17:30:37 +1100" MODIFIED_BY="Narelle S Willis"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-09-23 10:18:55 +1000" MODIFIED_BY="Gail Y Higgins">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-11-20 12:28:24 +1100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-09-29 13:52:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheng-1994">
<CHAR_METHODS MODIFIED="2008-09-29 13:51:50 +1000" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Method of random allocation: not described. However, states "since the investigators were not blind to the treatment previously recruited patients received, there might be a tendency to recruit older, less educated and diabetic patients with poorer eyesight and manual dexterity when treatment with UXVD was anticipated and to recruit younger and more educated patients when treatment with the O-set was anticipated."</P>
<P>Masking: not mentioned.</P>
<P>Description of withdrawals/dropouts: not mentioned.</P>
<P>Analysis on intention to treat basis: unclear.</P>
<P>Duration of follow-up: treatment group - 802 patient-months; control group - 838 patient-months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-09-29 13:26:14 +1000" MODIFIED_BY="[Empty name]">
<P>All 100 patients starting CAPD over two years in a tertiary referral and satellite centre.</P>
<P>38 in treatment and 31 in control groups (also 31 in UVXD group).</P>
<P>Exclusion criteria:<BR/>age &lt;10 or &gt;70 years, living related transplant anticipated within 6 months of treatment. Unable to afford Y-set.</P>
<P>Male:female ratio: treatment group - 20:18; control group - 17:14.</P>
<P>Age (mean, range): treatment group - 34.9 (21-59) years; control group - 46.1 (23-65) years.</P>
<P>Primary renal disease: treatment group - glomerulonephritis (11), pyelonephritis (3), diabetes mellitus (3), SLE/vasculitis/myeloma (1), unknown (13).</P>
<P>Co-morbidity: treatment group - diabetes (1); control group (3).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-09-29 13:52:04 +1000" MODIFIED_BY="[Empty name]">
<P>Y-set (O-set)(treatment) vs conventional spike (control) vs UVXD (excluded from this review).</P>
<P>Sodium hypochlorite disinfectant (Amuchina) was retained in O-set connections between exchanges.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis<BR/>Exit site infections<BR/>Hospitalisation<BR/>Costs<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>A third group used UVXD - data from this group not included in this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-09-29 13:52:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Churchill-1989">
<CHAR_METHODS MODIFIED="2008-09-29 13:52:11 +1000" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Method of random allocation - at co-ordinating centre "using variable blocking factor".</P>
<P>Masking: not mentioned.</P>
<P>Withdrawals/dropouts: numbers and reasons clearly stated; treatment group - 14 ( transplant - 5; haemodialyses - 4; intermittent peritoneal dialysis - 1; recovery of renal function - 1; discontinued dialysis - 3);<BR/>control group - 16 (transplant - 3; haemodialysis - 6; intermittent peritoneal dialysis - 3; recovery of renal function - 1; discontinued dialysis - 3).</P>
<P>Analysis on intention to treat basis: unclear.</P>
<P>Duration of follow-up: treatment group - 452 patient-months; control group - 467 patient-months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-09-29 13:26:21 +1000" MODIFIED_BY="[Empty name]">
<P>124 new CAPD patients.</P>
<P>61 were in treatment group and 63 in control group.</P>
<P>Exclusion criteria: age &lt;18, likely to die in 6 months, previous complications on CAPD.</P>
<P>Male:female ratio: not given.</P>
<P>age - not given.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Y-connector (plus Amuchina)(treatment) vs standard spike (Baxter II and III)(control).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis<BR/>Exit site infections Technique survival (Kaplan- Meier).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Hypochlorite disinfectant in Y-set.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-09-29 13:27:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dryden-1992">
<CHAR_METHODS>
<P>RCT </P>
<P>Method of random allocation: not described. </P>
<P>Masking: not mentioned</P>
<P>Description of withdrawals and dropouts: numbers and reasons clearly stated; treatment group - 12 (died - 3; transplant - 5; haemodialysis - 1; recurrent infection - 1; catheter failure -1; recovery of renal function - 1);<BR/>control group - 12 (died - 3; transplant - 5; haemodialysis - 1; recurrent infections - 2; catheter failure - 1). </P>
<P>Analysis on intention to treat basis: unclear.</P>
<P>Duration of follow-up (mean, range):14.1 (3 - 36) months. treatment group - 564 - patient-months; control group - 564 patient-months. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-09-29 13:27:31 +1000" MODIFIED_BY="[Empty name]">
<P>80 CAPD patients (new and established) at a single centre</P>
<P>40 in treatment and 40 in control groups.</P>
<P>Male:female ratio: treatment group - 23:17; control group - 26:14.</P>
<P>Age (mean, range): 49 (20 - 67) years.</P>
<P>Co-morbidity: treatment group - diabetes (5); control group (7).<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Y-set (Freeline Solo) using drain/flush/fill (treatment) vs standard (Baxter II)(control).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis<BR/>Exit site infections</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Hypochlorite not used in this system. Povidone iodine cap protectors used.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-20 12:28:01 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Harris-1996">
<CHAR_METHODS MODIFIED="2013-11-20 12:28:00 +1100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Method of random allocation: not described but states "patients stratified into three groups".</P>
<P>Masking: not mentioned</P>
<P>Description of withdrawals and dropouts: numbers and reasons clearly stated. Overall - 10 (died - 2; transplant - 3; recovery of renal function - 1; blindness - 1; transfer to other unit - 1; haemodialysis - 2). It also stated " no differences in reasons for early termination between patients on the basic Y or Freeline Solo systems".</P>
<P>Analysis on intention to treat basis: data from Group 3 were not analysed because of its high dropout rate but data from the other two groups "were analysed on an intention to treat basis".</P>
<P>Duration of follow-up (mean, SD): treatment group: group 1 - 9.1(3.9) months; group 2 - 9.9(3.5) months; control group: group 1 8.5(3.2) months; group 2 - 11.5(3.6) months<BR/>treatment group - 328 patient-months; control group - 303 patient-months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-11-20 12:28:01 +1100" MODIFIED_BY="[Empty name]">
<P>New and established CAPD patients - group 1 - new patients (39); group 2 - established patients with no peritonitis or exit site infections in previous 12 months or with new catheter (24); group 3 - established patients with 1-3 catheter-related infections in previous 12 months (9). Because of high dropout rate data from group 3 were not reported nor analysed.</P>
<P>Overall: 33 in treatment group and 30 in control group.</P>
<P>Inclusion criteria: &#8805; 18 years old; ability to perform exchanges without nursing assistance; informed consent.</P>
<P>Exclusion criteria: within 2 months of catheter-related infection; more than 3 separate catheter-related infections in previous year unless catheter subsequently replaced.</P>
<P>Male:female ratio: treatment group - 13:20; control group - 11:19.</P>
<P>Age (mean, SD): treatment group - group 1 - 55(17) years; group 2 - 59(11) years; control group - group 1 - 51(17) years; group 2 - 60(15) years.</P>
<P>Co-morbidity: treatment group - diabetes (9); control group - diabetes (6).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Double bag (Baxter Freeline Solo)(treatment) vs Basic Y (control).</P>
<P>All had double-cuffed silastic Tenckhoff catheters. Catheters immobilised.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis<BR/>Exit site infections<BR/>Cost<BR/>Training time<BR/>Hospitalisation<BR/>Catheter removal<BR/>"Ease of use" scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Data from group 3 not reported nor analysed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-20 12:28:05 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kiernan-1995">
<CHAR_METHODS MODIFIED="2013-11-20 12:28:02 +1100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Method of random allocation: not described but states "stratified for race and than randomly assigned".</P>
<P>Masking: patients and healthcare workers not masked.</P>
<P>Description of withdrawals and dropouts: numbers and reasons clearly stated; treatment group - 4 (transplant - 1; CAPD drainage problems - 2; recovery of renal function - 1); control group - 15 (haemodialysis - 5; transplant - 3; transfer to other unit - 1; CCPD - 1; died - 1).</P>
<P>Analysis on intention to treat basis: unclear.</P>
<P>Duration of follow-up (mean, SD): treatment group - 4.1(2.6) months; control group - 4.3(2.5) months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-11-20 12:28:03 +1100" MODIFIED_BY="[Empty name]">
<P>35 new and 47 established CAPD patients in single unit.</P>
<P>41 in treatment and 41 in control groups.</P>
<P>Male:female ratio:</P>
<P>Age (mean,SD): treatment group - 54.1(15.2) years; control group - 55.2(14.5) years.</P>
<P>Co-morbidity: treatment group - diabetes (15); HIV positive (4); cardiovascular disease (20); control group - diabetes (10); HIV positive (4); cardiovascular disease (13).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>UltraTwin bag system (Baxter) (luer lock between Tenckhoff and double bag, no spiking required, flush/drain/fill)(treatment) vs Ultra Y-set system (Baxter) (luer lock between catheter and Y-set, new dialysate bag spiked, flush/drain/fill)(control).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-11-20 12:28:05 +1100" MODIFIED_BY="[Empty name]">
<P>Treatment group - whites (19); African-americans (22); control group - whites (18); African-americans (23).</P>
<P>Study terminated at interim analysis (300 patient-months) because of statistically significant difference in infection rates between groups.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-20 12:28:09 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-1996">
<CHAR_METHODS MODIFIED="2013-11-20 12:28:07 +1100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Method of random allocation: not described.</P>
<P>Masking: states single-blinded but unclear who is blinded patients, healthcare providers or healthcare assessors.</P>
<P>Description of withdrawals and dropouts: numbers and reasons clearly stated; total - 4 (died - 3; transplant - 1)</P>
<P>Analysis on intention to treat basis: unclear</P>
<P>Duration of follow-up: 12 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-11-20 12:28:09 +1100" MODIFIED_BY="[Empty name]">
<P>40 new ESRD patients in single unit.</P>
<P>20 in treatment group and 20 in control group.</P>
<P>Male:female ratio: treatment group - 9:11; control group - 6:14.</P>
<P>Age (mean,SD): treatment group - 50(8) years; control group 47(15) years.</P>
<P>Co-morbidity: treatment group - diabetes (5); HBsAg carriers (2); control group - diabetes (4); HBsAg carriers (3).<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Y-set (Ultraset, Baxter) with drain/flush/fill (treatment) vs conventional spike (control).</P>
<P>3 exchanges per day.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis<BR/>Exit site infections<BR/>Hospitalisation<BR/>Duration of training <BR/>Mortality<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-20 12:28:14 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-1999">
<CHAR_METHODS>
<P>RCT</P>
<P>Method of random allocation: not described; states randomisation was single-blinded but remains unclear who was blinded. </P>
<P>Masking:<BR/>states single- blinded study but unclear who was blinded. </P>
<P>Description of withdrawals and dropouts: numbers and reasons clearly stated - treatment group - 9 (opted not to use Y-set - 7; incomplete data - 2). </P>
<P>Analysis on intention to treat basis: no</P>
<P>Duration of follow-up:<BR/>all patients followed for at least 12 months.<BR/>Treatment group - 937 patient-months; control group - 734 patient-months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-11-20 12:28:14 +1100" MODIFIED_BY="[Empty name]">
<P>120 new ESRD patients admitted to CAPD programme.</P>
<P>60 in treatment group and 60 in control group (data on only 51 reported, see above).</P>
<P>Male:female ratio: treatment group - 28:32; control group - 26:25.</P>
<P>Age (mean,SD): treatment group - 53.4(13.4) years; control group 49.3(14.2) years.<BR/>Primary renal disease: treatment group - glomerulonephritis (14); diabetes (11); adult polycystic kidney disease (2); hypertension (3); renal stone disease (5); others/unknown (25); control group - glomerulonephritis (13); diabetes (11); adult polycystic kidney disease (4); hypertension (3); renal stone disease (0); others/unknown (20).</P>
<P>Co-morbidity: treatment group - diabetes (15); HBsAg carriers (10); control group - diabetes (14); HBsAg carriers (5).<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Double bag disconnect system (Ultrabag, Baxter) "pre-assembled and sterilised as single unit". (treatment) vs Y-set disconnect system (Ultraset, Baxter)(control).</P>
<P>3 exchanges per day.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis<BR/>Exit site infections<BR/>Patient acceptance<BR/>Hospitalisation<BR/>Catheter removal<BR/>Mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-09-29 13:28:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindholm-1988">
<CHAR_METHODS>
<P>RCT</P>
<P>Method of random allocation: not described.</P>
<P>Masking: not mentioned.</P>
<P>Description of withdrawals and dropouts: not mentioned.</P>
<P>Analysis on intention to treat basis: unclear.</P>
<P>Duration of follow-up: treatment group - 284 patient-months; control group 255 patient-months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-09-29 13:28:31 +1000" MODIFIED_BY="[Empty name]">
<P>58 patients with ESRD.</P>
<P>35 in treatment group and 23 in control group.</P>
<P>Co-morbidity: overall - diabetes (15).<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Y-set (5F "safe-lock" take-off system, Fresenius, flush/drain/fill)(treatment) vs conventional CAPD systems (control).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Authors stated that "we had problems with this study. The number of patients was envisaged to be 140, 58 were enrolled."</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-20 12:28:16 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maiorca-1983">
<CHAR_METHODS MODIFIED="2013-11-20 12:28:15 +1100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Method of random allocation: "closed envelope system" but no other details reported.</P>
<P>Masking: not mentioned.</P>
<P>Description of withdrawals and dropouts: number and reasons clearly stated - treatment group - 6 (died - 2; withdrawn because additives to CAPD bags - 1; CAPD stopped because of loss of ultrafiltration - 1; patient request to withdraw from trial - 1; progressive mental deterioration - 1); control group (died - 1; withdrawn because additives to CAPD bags - 1; recurrent peritonitis and switched to Y-set - 4; CAPD stopped because of loss of ultrafiltration - 1; patient request to withdraw from trial - 1; withdrew because of recurrent exit site infections - 2).</P>
<P>Analysis on intention to treat basis: no</P>
<P>Duration of follow-up (mean,SD): treatment group - 11.3(5.6)(range 3-24) months; control group - 11.7(6.1)(range 3-24) months.<BR/>treatment group - 363 patient-months; control group - 351 patient-months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-11-20 12:28:16 +1100" MODIFIED_BY="[Empty name]">
<P>62 new CAPD patients .</P>
<P>32 in treatment and 30 in control groups.</P>
<P>Exclusion criteria: diabetes</P>
<P>Male:female ratio: treatment group - 17:15; control group - 19:11.</P>
<P>Age (mean,SD): treatment group - 55.1(14.3)(range 12-75) years; control group 55.5(17.5)(range 14-80) years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Y-connector with disinfectant (sodium hypochlorite, Amuchina) (Travenol, Lessines)(flush/drain/fill) (treatment) vs Standard (Travenol spike) (control).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis <BR/>Mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Hypochlorite used.</P>
<P>Kaplan-Meir analysis also reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-20 12:28:16 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Monteon-1998">
<CHAR_METHODS MODIFIED="2013-11-20 12:28:16 +1100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Method of random allocation: "done centrally by one of the researchers following the Moses-Oakford method as described by Meinert, with the use of a list of random numbers. The order of allocation was sent to each participant centre in sealed envelopes. A copy of the assignment list was kept in the coordinating centre. At least three audit visits were done to each centre by trained nurses to certify that the envelopes were used in the order provided and that their content remained unknown to the personnel of the centre until the initiation of the treatment." Uneven randomisation in proportion double bag:Y-set:standard system - 2:2:1.</P>
<P>Masking: none</P>
<P>Description of withdrawals and dropouts: number and reasons clearly stated - total<BR/>- 59 (randomised but did not begin study - 7; transplant - 10; died - 23; technique failure - 8; others - 11) states "no significant difference in dropouts or deaths among the groups"</P>
<P>Analysis on intention to treat basis: no</P>
<P>Duration of follow-up: "time at risk per patient" - double bag - 10.6 months; Y-set 11.8 months; standard system - 11.6 months.<BR/>Total follow-up: double bag - 645.1 patient-months; Y-set - 670.8 patient-months; standard system - 337.4 patient-months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-11-20 12:28:16 +1100" MODIFIED_BY="[Empty name]">
<P>154 new ESRD<BR/>patients</P>
<P>147/154 randomised patients began study: double bag - 61; Y-set - 57; standard system - 29.</P>
<P>Exclusion criteria: previous abdominal surgery, abdominal hernias, diverticulosis, cancer, AIDS.</P>
<P>Male:female ratio: double bag - 33:28; Y-set - 37:20; standard system - 15:14.</P>
<P>Age (mean,SD): double bag - 43.6(21.9) years; Y-set - 43.2(21.3) years; standard system - 39.7(19.0) years.</P>
<P>Co-morbidity: diabetes - double bag (20), Y-set (19), standard system (15).<BR/>"High risk, low educational and socioeconomic levels with high prevalence of malnutrition."<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Double bag vs Y-set vs standard spike system.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis<BR/>Exit site infections<BR/>Hospitalisation<BR/>Catheter removal<BR/>Cost</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Kaplan-Meir analysis also reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-20 12:28:23 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Owen-1992">
<CHAR_METHODS>
<P>RCT</P>
<P>Method of random allocation: not described. </P>
<P>Masking: not mentioned. </P>
<P>Description of withdrawals and dropouts: numbers and reasons clearly stated - treatment group - 20 (died - 3; transplant - 11; haemodialysis - 3; intermittent peritoneal dialysis or other CAPD system - 3); control - 18 (died - 5; transplanted - 3; haemodialysis - 10; transferred to intermittent peritoneal dialysis or CAPD - 0).</P>
<P>Analysis on intention to treat basis: unclear.</P>
<P>Duration of follow-up (median, range): treatment group - 9 (1-33) months; control group - 14 (1-34) months.<BR/>treatment group - 375 patient-months; control group - 430 patient-months. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-09-29 13:29:14 +1000" MODIFIED_BY="[Empty name]">
<P>60 patients commencing CAPD.</P>
<P>30 in treatment group and 30 in control group.</P>
<P>Inclusion criteria: "patients who could tolerate 2L fluid exchanges".</P>
<P>Exclusion criteria: "Significant physical disabilities or severe visual impairment".</P>
<P>Male:female ratio: treatment group - 16:14; control group - 15:15.</P>
<P>Age (median, range): treatment group - 54 (11-79) years; control group - 56 (16-75) years.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-11-20 12:28:23 +1100" MODIFIED_BY="[Empty name]">
<P>Y-set modification (O-system "modification of the Y-system with the ends of the connector joined to each other to form a closed circuit between exchanges"; flush before fill, ends soaked in hypochlorite prior to exchange) vs standard system (luer lock, System II, Baxter)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis.<BR/>Exit site infection.<BR/>Technique failure<BR/>Training time<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Povidone iodine caps used.</P>
<P>Kaplan-Meir analysis also reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-20 12:28:24 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rottembourg-1987">
<CHAR_METHODS>
<P>RCT</P>
<P>Method of random allocation: not described.</P>
<P>Masking: not mentioned. </P>
<P>Description of withdrawals and dropouts: not mentioned. </P>
<P>Analysis on intention to treat basis: unclear.</P>
<P>Duration of follow-up: treatment group - 277 patient-months (range 2-24); control group - 344 patient-months (range, 2-24).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-11-20 12:28:24 +1100" MODIFIED_BY="[Empty name]">
<P>55 new CAPD patients</P>
<P>27 patients in treatment group and 28 patients in control group.</P>
<P>Exclusion criteria: three new patients excluded because they were "returning to Africa".</P>
<P>Male:female ratio: treatment group - 12:15; control group - 16:12.</P>
<P>Age (mean,SD): treatment group - 48.6(13.2) years; control group - 54.6(14.6) years.</P>
<P>Primary renal disease: treatment group - diabetes (9); glomerulonephritis (6), interstitial nephritis (8); others/unknown (3); nephroangiosclerosis (1); control group - diabetes (10); glomerulonephritis (11), interstitial nephritis (3); others/unknown (2); nephroangiosclerosis (2)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Y-set systems (3 different systems used - Y-set disposable disconnect system, one time use, two connections only, no disinfectant used, flush/drain/fill (Travenol); O-set reusable system, no disinfectant, reused for one month (Travenol) and 5F safe-lock system, flush/drain/fill (Fresenius)) (treatment) vs standard systems (luer lock or Reverse system (Travenol) or safe-lock with spray of chlorhexidine (Fresenius) (control).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peritonitis</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-09-23 10:18:55 +1000" MODIFIED_BY="Gail Y Higgins" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Amato-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT though reports data from two previously published RCTs</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-20 11:29:32 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bailie-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-20 11:29:32 +1100" MODIFIED_BY="[Empty name]">
<P>Compares O-set with UVXD germicidal system</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Balteau-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Buoncristiani-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-20 11:30:10 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burkart-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-20 11:30:10 +1100" MODIFIED_BY="[Empty name]">
<P>Compared standard spike with Ultraset</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cancarini-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT but patients randomised to "flushing" versus "flushing plus in line disinfectant" not to Y-set, double-bag or standard spike systems</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-09-22 16:35:47 +1000" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Correa_x002d_Rotter-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-09-22 16:35:47 +1000" MODIFIED_BY="Narelle S Willis">
<P>Abstract only publication, no data available September 2016</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-20 11:31:02 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-Fijter-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-20 11:31:02 +1100" MODIFIED_BY="[Empty name]">
<P>Compared Y-connector CAPD with CCPD</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Durand-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Garcia_x002d_Lopez-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hall-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Possible quasi-RCT but compares two non-disconnect systems</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Holley-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Huang-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Junor-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-01-08 08:57:56 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Lee-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-01-08 08:57:56 +1100" MODIFIED_BY="Narelle S Willis">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lempert-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-20 12:28:29 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ong-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-20 12:28:29 +1100" MODIFIED_BY="[Empty name]">
<P>Comparisons not relevant to this review. Study compared two Y-disconnect systems.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Orange-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Piraino-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Port-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ryckelynck-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Probable RCT but patients randomised to "soaking" or not "soaking" connectors in povidone iodine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Smith-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT and specifically concerns automated peritoneal dialysis and not CAPD</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Smith-1997a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT and specifically concerns automated peritoneal dialysis and not CAPD</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-20 11:32:18 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tan-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-20 11:32:18 +1100" MODIFIED_BY="[Empty name]">
<P>Compared ANDY.disc system to Ultrabag system</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tielens-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Viglino-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT but comparing Y-set and modification of Y-set (Y-set with two short branches) no comparison with standard spike or double-bag systems</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Viglino-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT but comparing Y-set and modification of Y-set (T-set with disinfectant) no comparison with standard spike or double-bag systems</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-20 11:39:24 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wong-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-20 11:39:24 +1100" MODIFIED_BY="[Empty name]">
<P>Compared ANDY-Disc system with UltraBag system</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wust-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2016-09-22 16:35:11 +1000" MODIFIED_BY="Narelle S Willis" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-Cheng-1994">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Churchill-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dryden-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Harris-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kiernan-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Li-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Li-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lindholm-1988">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Maiorca-1983">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Monteon-1998">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Owen-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rottembourg-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2013-11-20 11:43:37 +1100" MODIFIED_BY="Narelle S Willis">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-11-20 11:43:37 +1100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE>Number of patient-months on CAPD per episode of peritonitis</TITLE>
<TABLE COLS="4" ROWS="13">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Double bag systems</P>
</TH>
<TH>
<P>Y-set systems</P>
</TH>
<TH>
<P>Standard systems</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Cheng-1994" TYPE="STUDY">Cheng 1994</LINK>
</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>30.8</P>
</TD>
<TD>
<P>21.5</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Churchill-1989" TYPE="STUDY">Churchill 1989</LINK>
</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>21.53</P>
</TD>
<TD>
<P>9.93</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Li-1996" TYPE="STUDY">Li 1996</LINK>
</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>17.0</P>
</TD>
<TD>
<P>11.4</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lindholm-1988" TYPE="STUDY">Lindholm 1988</LINK>
</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>22.0</P>
</TD>
<TD>
<P>8.0</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Maiorca-1983" TYPE="STUDY">Maiorca 1983</LINK>
</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>33.0</P>
</TD>
<TD>
<P>11.3</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Owen-1992" TYPE="STUDY">Owen 1992</LINK>
</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>13.4</P>
</TD>
<TD>
<P>4.9</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Rottembourg-1987" TYPE="STUDY">Rottembourg 1987</LINK>
</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>23.0</P>
</TD>
<TD>
<P>12.3</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dryden-1992" TYPE="STUDY">Dryden 1992</LINK>
</P>
</TD>
<TD>
<P>25.0</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>9.7</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Monteon-1998" TYPE="STUDY">Monteon 1998</LINK>
</P>
</TD>
<TD>
<P>24.8</P>
</TD>
<TD>
<P>11.8</P>
</TD>
<TD>
<P>6.1</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Harris-1996" TYPE="STUDY">Harris 1996</LINK>
</P>
</TD>
<TD>
<P>46.4</P>
</TD>
<TD>
<P>14.0</P>
</TD>
<TD>
<P>--</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kiernan-1995" TYPE="STUDY">Kiernan 1995</LINK>
</P>
</TD>
<TD>
<P>33.9</P>
</TD>
<TD>
<P>11.7</P>
</TD>
<TD>
<P>--</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Li-1999" TYPE="STUDY">Li 1999</LINK>
</P>
</TD>
<TD>
<P>33.5</P>
</TD>
<TD>
<P>29.4</P>
</TD>
<TD>
<P>--</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2013-11-20 11:43:37 +1100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE>Number of patient-months on CAPD per episode of exit-site infection</TITLE>
<TABLE COLS="4" ROWS="5">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Double bag systems</P>
</TH>
<TH>
<P>Y-set systems</P>
</TH>
<TH>
<P>Standard systems</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Cheng-1994" TYPE="STUDY">Cheng 1994</LINK>
</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>14.9</P>
</TD>
<TD>
<P>16.4</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Li-1996" TYPE="STUDY">Li 1996</LINK>
</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>26.4</P>
</TD>
<TD>
<P>21.6</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kiernan-1995" TYPE="STUDY">Kiernan 1995</LINK>
</P>
</TD>
<TD>
<P>28.3</P>
</TD>
<TD>
<P>12.5</P>
</TD>
<TD>
<P>--</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Li-1999" TYPE="STUDY">Li 1999</LINK>
</P>
</TD>
<TD>
<P>17.4</P>
</TD>
<TD>
<P>16.0</P>
</TD>
<TD>
<P>--</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-11-20 12:27:20 +1100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-11-20 12:23:29 +1100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Y-set systems versus standard systems</NAME>
<DICH_OUTCOME CHI2="6.445567443171226" CI_END="0.7699677649537991" CI_START="0.5332470907092259" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6407675636309149" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="137" I2="6.91277295753509" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.11352745638041757" LOG_CI_START="-0.27307150529696045" LOG_EFFECT_SIZE="-0.19329948083868895" METHOD="MH" MODIFIED="2013-11-20 12:20:52 +1100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.375169116209333" P_Q="1.0" P_Z="2.041378309393349E-6" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.004373505980084735" TOTALS="YES" TOTAL_1="262" TOTAL_2="223" WEIGHT="100.00000000000001" Z="4.749284266595258">
<NAME>Number of patients with peritonitis</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8600260571329564" CI_START="0.31006291655039697" EFFECT_SIZE="0.5163934426229508" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="30" LOG_CI_END="-0.06548839027082547" LOG_CI_START="-0.5085501721715076" LOG_EFFECT_SIZE="-0.2870192812211665" ORDER="3898" O_E="0.0" SE="0.2602566838796524" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.06773354150403331" WEIGHT="12.18032032175524"/>
<DICH_DATA CI_END="1.3032399154297964" CI_START="0.3107322549681106" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.11502437300812106" LOG_CI_START="-0.5076136632960575" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="3899" O_E="0.0" SE="0.36574066463306176" STUDY_ID="STD-Li-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.13376623376623376" WEIGHT="6.357959971732029"/>
<DICH_DATA CI_END="0.8893675955887811" CI_START="0.38364826341508557" EFFECT_SIZE="0.5841269841269842" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="18" LOG_CI_END="-0.050918698266167704" LOG_CI_START="-0.41606676329396036" LOG_EFFECT_SIZE="-0.23349273078006402" ORDER="3900" O_E="0.0" SE="0.2144897809093985" STUDY_ID="STD-Lindholm-1988" TOTAL_1="35" TOTAL_2="23" VAR="0.04600586611456177" WEIGHT="17.433463326270854"/>
<DICH_DATA CI_END="1.006535329870023" CI_START="0.3021451911954777" EFFECT_SIZE="0.5514705882352942" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="17" LOG_CI_END="0.0028290234356131497" LOG_CI_START="-0.5197843133926481" LOG_EFFECT_SIZE="-0.25847764497851744" ORDER="3901" O_E="0.0" SE="0.30698566103066016" STUDY_ID="STD-Maiorca-1983" TOTAL_1="32" TOTAL_2="30" VAR="0.09424019607843137" WEIGHT="8.906337734804934"/>
<DICH_DATA CI_END="1.2253040461345899" CI_START="0.646961614971472" EFFECT_SIZE="0.8903508771929824" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="20" LOG_CI_END="0.08824386761834101" LOG_CI_START="-0.18912148579282279" LOG_EFFECT_SIZE="-0.050438809087240875" ORDER="3902" O_E="0.0" SE="0.16292578157436013" STUDY_ID="STD-Monteon-1998" TOTAL_1="57" TOTAL_2="29" VAR="0.02654481030161611" WEIGHT="28.40668708510468"/>
<DICH_DATA CI_END="0.7740885352276816" CI_START="0.34732649020251843" EFFECT_SIZE="0.5185185185185185" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="27" LOG_CI_END="-0.11120936468932852" LOG_CI_START="-0.4592620922721701" LOG_EFFECT_SIZE="-0.2852357284807493" ORDER="3903" O_E="0.0" SE="0.20444789507094907" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.0417989417989418" WEIGHT="19.021883786969763"/>
<DICH_DATA CI_END="1.2762878654636114" CI_START="0.34823213200652037" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="14" LOG_CI_END="0.10594864012372557" LOG_CI_START="-0.45813115823508804" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="3904" O_E="0.0" SE="0.33134326579600165" STUDY_ID="STD-Rottembourg-1987" TOTAL_1="27" TOTAL_2="28" VAR="0.10978835978835978" WEIGHT="7.6933477733625155"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.638437920383844" CI_END="0.6092787497729552" CI_START="0.3993024236348676" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4932407945958678" ESTIMABLE="YES" EVENTS_1="182" EVENTS_2="360" I2="27.374123713594138" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.21518396879377047" LOG_CI_START="-0.3986980537724674" LOG_EFFECT_SIZE="-0.30694101128311896" METHOD="MH" MODIFIED="2013-11-20 12:21:32 +1100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.21000536919145196" P_Q="1.0" P_Z="5.513250526754336E-11" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.024873320763794053" TOTALS="YES" TOTAL_1="3462" TOTAL_2="3955" WEIGHT="100.0" Z="6.556372254075766">
<NAME>Peritonitis rate</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2548489517821195" CI_START="0.5123991361546122" EFFECT_SIZE="0.8018625311720698" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="64" LOG_CI_END="0.09859145222699932" LOG_CI_START="-0.29039161109675293" LOG_EFFECT_SIZE="-0.09590007943487679" ORDER="3905" O_E="0.0" SE="0.22849057689358954" STUDY_ID="STD-Cheng-1994" TOTAL_1="802" TOTAL_2="1583" VAR="0.05220794372916535" WEIGHT="15.075272763320463"/>
<DICH_DATA CI_END="0.7595362607794666" CI_START="0.28057647383743145" EFFECT_SIZE="0.4616362266993033" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="47" LOG_CI_END="-0.11945148779129472" LOG_CI_START="-0.5519487471028417" LOG_EFFECT_SIZE="-0.3357001174470682" ORDER="3906" O_E="0.0" SE="0.2540510310155642" STUDY_ID="STD-Churchill-1989" TOTAL_1="452" TOTAL_2="467" VAR="0.06454192636007115" WEIGHT="12.995782313985965"/>
<DICH_DATA CI_END="1.3068553037610986" CI_START="0.3453718351832087" EFFECT_SIZE="0.6718266253869969" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.11622750475202598" LOG_CI_START="-0.46171308171717274" LOG_EFFECT_SIZE="-0.17274278848257338" ORDER="3907" O_E="0.0" SE="0.33948516134404955" STUDY_ID="STD-Li-1996" TOTAL_1="238" TOTAL_2="217" VAR="0.11525017477279537" WEIGHT="8.29283542151988"/>
<DICH_DATA CI_END="0.6934879289478691" CI_START="0.19510126803279051" EFFECT_SIZE="0.36783199195171024" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.15896109398068367" LOG_CI_START="-0.7097399079614317" LOG_EFFECT_SIZE="-0.43435050097105765" ORDER="3908" O_E="0.0" SE="0.3235302017313914" STUDY_ID="STD-Lindholm-1988" TOTAL_1="284" TOTAL_2="225" VAR="0.10467179143235482" WEIGHT="8.97001104459699"/>
<DICH_DATA CI_END="0.6718731624632677" CI_START="0.1752167706166355" EFFECT_SIZE="0.34310850439882695" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="31" LOG_CI_END="-0.172712706174577" LOG_CI_START="-0.7564243283180953" LOG_EFFECT_SIZE="-0.46456851724633613" ORDER="3909" O_E="0.0" SE="0.3428750962662322" STUDY_ID="STD-Maiorca-1983" TOTAL_1="363" TOTAL_2="351" VAR="0.11756333163957798" WEIGHT="8.15816061081131"/>
<DICH_DATA CI_END="0.7360977438007774" CI_START="0.3680472754966758" EFFECT_SIZE="0.5204985774285327" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="55" LOG_CI_END="-0.1330645134140937" LOG_CI_START="-0.4340963928247182" LOG_EFFECT_SIZE="-0.28358045311940594" ORDER="3910" O_E="0.0" SE="0.17682761609763642" STUDY_ID="STD-Monteon-1998" TOTAL_1="671" TOTAL_2="337" VAR="0.031268005814773084" WEIGHT="20.698140888188988"/>
<DICH_DATA CI_END="0.5467071977654312" CI_START="0.24461772991495542" EFFECT_SIZE="0.3656969696969697" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="88" LOG_CI_END="-0.26224520829386244" LOG_CI_START="-0.6115120684560109" LOG_EFFECT_SIZE="-0.4368786383749367" ORDER="3911" O_E="0.0" SE="0.2051610825580871" STUDY_ID="STD-Owen-1992" TOTAL_1="375" TOTAL_2="431" VAR="0.04209106979640623" WEIGHT="17.352821065822543"/>
<DICH_DATA CI_END="1.0271699534937255" CI_START="0.27577917583898554" EFFECT_SIZE="0.5322331098504384" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="28" LOG_CI_END="0.01164230704221668" LOG_CI_START="-0.5594385306172425" LOG_EFFECT_SIZE="-0.27389811178751283" ORDER="3912" O_E="0.0" SE="0.3354557109369043" STUDY_ID="STD-Rottembourg-1987" TOTAL_1="277" TOTAL_2="344" VAR="0.1125305340001839" WEIGHT="8.456975891753869"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.05409737587256082" CI_END="1.4647088103734536" CI_START="0.7150912207765308" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0234258210989662" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="36" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.1657512938930434" LOG_CI_START="-0.145638553789242" LOG_EFFECT_SIZE="0.010056370051900734" METHOD="MH" MODIFIED="2013-11-20 12:21:45 +1100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8160810172824422" P_Q="1.0" P_Z="0.8992613397269507" Q="0.0" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="93" WEIGHT="100.0" Z="0.12659451336411612">
<NAME>Number of patients with exit site/tunnel infection</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5751847038249802" CI_START="0.6195546668044932" EFFECT_SIZE="0.9878831076265147" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="23" LOG_CI_END="0.19733148583914029" LOG_CI_START="-0.20792036734428418" LOG_EFFECT_SIZE="-0.005294440752571952" ORDER="3913" O_E="0.0" SE="0.23804694458896963" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.056666347828143976" WEIGHT="59.04170344617619"/>
<DICH_DATA CI_END="1.8856585761492402" CI_START="0.615044169861256" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.2754630606613981" LOG_CI_START="-0.21109369391859562" LOG_EFFECT_SIZE="0.032184683371401235" ORDER="3914" O_E="0.0" SE="0.2858058461350672" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.0816849816849817" WEIGHT="40.958296553823814"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9595592745461476" CI_END="1.6926808692953812" CI_START="0.9067786605114475" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2389055215523976" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="91" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.22857508582989722" LOG_CI_START="-0.04249870880486403" LOG_EFFECT_SIZE="0.0930381885125166" METHOD="MH" MODIFIED="2013-11-20 12:22:07 +1100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.32729813260642693" P_Q="1.0" P_Z="0.17849572135252478" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1041" TOTAL_2="1800" WEIGHT="99.99999999999999" Z="1.3454011585079781">
<NAME>Exit-site/tunnel infection rate</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.8348324217187004" CI_START="0.9413514924563906" EFFECT_SIZE="1.3142382731423827" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="81" LOG_CI_END="0.263596405565636" LOG_CI_START="-0.02624818450964856" LOG_EFFECT_SIZE="0.11867411052799373" ORDER="3915" O_E="0.0" SE="0.17025614696408245" STUDY_ID="STD-Cheng-1994" TOTAL_1="803" TOTAL_2="1583" VAR="0.028987155579055242" WEIGHT="87.46708904163727"/>
<DICH_DATA CI_END="1.981425977526384" CI_START="0.33983861095015233" EFFECT_SIZE="0.8205882352941176" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.2969778525206713" LOG_CI_START="-0.46872728005798653" LOG_EFFECT_SIZE="-0.08587471376865759" ORDER="3916" O_E="0.0" SE="0.44977898517823905" STUDY_ID="STD-Li-1996" TOTAL_1="238" TOTAL_2="217" VAR="0.2023011355079666" WEIGHT="12.532910958362725"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9198342976762985" CI_END="1.0519648797258878" CI_START="0.1925398433149308" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4500501673316348" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.022001240962346538" LOG_CI_START="-0.7154793859408619" LOG_EFFECT_SIZE="-0.34673907248925767" METHOD="MH" MODIFIED="2013-11-20 12:22:18 +1100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.3375186243830641" P_Q="1.0" P_Z="0.06532596310351899" Q="0.0" RANDOM="YES" SCALE="20.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="93" WEIGHT="100.0" Z="1.843020872196993">
<NAME>Number of patients switched to HD</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.3209434292632753" CI_START="0.2042557803362291" EFFECT_SIZE="0.6885245901639344" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3656645550796966" LOG_CI_START="-0.6898256443054298" LOG_EFFECT_SIZE="-0.16208054461286658" ORDER="3917" O_E="0.0" SE="0.620000167879574" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.3844002081706999" WEIGHT="48.819443241464135"/>
<DICH_DATA CI_END="0.9829906466729277" CI_START="0.09155733099253573" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="-0.007450614535779605" LOG_CI_START="-1.0383068760248957" LOG_EFFECT_SIZE="-0.5228787452803376" ORDER="3918" O_E="0.0" SE="0.6055300708194984" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.3666666666666667" WEIGHT="51.18055675853586"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3447534018942141" CI_END="1.4577672615177324" CI_START="0.7553833155813424" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0493679370703102" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="34" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.16368819263296647" LOG_CI_START="-0.1218326118184992" LOG_EFFECT_SIZE="0.020927790407233603" METHOD="MH" MODIFIED="2013-11-20 12:22:41 +1100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.5570984245040669" P_Q="1.0" P_Z="0.7738684008092404" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="93" WEIGHT="100.0" Z="0.2873185759824595">
<NAME>Number of patients no longer on allocated treatment for whatever reason</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6881852263708894" CI_START="0.4837460586191216" EFFECT_SIZE="0.9036885245901639" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.2274200953569103" LOG_CI_START="-0.3153825604266544" LOG_EFFECT_SIZE="-0.04398123253487209" ORDER="3919" O_E="0.0" SE="0.3188449669237461" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.10166211293260473" WEIGHT="27.66888060910416"/>
<DICH_DATA CI_END="1.6353725305206617" CI_START="0.754915395846543" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="18" LOG_CI_END="0.21361669859922858" LOG_CI_START="-0.12210171747787829" LOG_EFFECT_SIZE="0.04575749056067514" ORDER="3920" O_E="0.0" SE="0.19720265943665385" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.03888888888888888" WEIGHT="72.33111939089584"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:22:52 +1100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="50.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients who had CAPD catheter removed</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.938902847851195" CI_START="0.03780700379134716" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.46818522971347326" LOG_CI_START="-1.4224277391527982" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="3921" O_E="0.0" SE="1.1105554165971787" STUDY_ID="STD-Li-1996" TOTAL_1="20" TOTAL_2="20" VAR="1.2333333333333332" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="22" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:23:00 +1100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients hospitalised (all cause)</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5647755214808194" CI_START="0.8068905703637201" EFFECT_SIZE="1.1236559139784945" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="24" LOG_CI_END="0.19445204362389634" LOG_CI_START="-0.09318535983762101" LOG_EFFECT_SIZE="0.050633341893137646" ORDER="3922" O_E="0.0" SE="0.16895963462140562" STUDY_ID="STD-Cheng-1994" TOTAL_1="31" TOTAL_2="38" VAR="0.028547358131398887" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:23:11 +1100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients hospitalised (peritonitis)</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4448139847532715" CI_START="0.25999911972620016" EFFECT_SIZE="0.6129032258064516" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.15981193664591378" LOG_CI_START="-0.5850281224088013" LOG_EFFECT_SIZE="-0.21260809288144372" ORDER="3923" O_E="0.0" SE="0.4375227377064954" STUDY_ID="STD-Cheng-1994" TOTAL_1="31" TOTAL_2="38" VAR="0.19142614601018676" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.8356646794553209" CI_END="2.207345469884027" CI_START="0.48323944398560575" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.032800269921974" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.34387030956523584" LOG_CI_START="-0.3158376240430692" LOG_EFFECT_SIZE="0.014016342761083253" METHOD="MH" MODIFIED="2013-11-20 12:23:29 +1100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.7659512797414997" P_Q="1.0" P_Z="0.9336257964044562" Q="0.0" RANDOM="YES" SCALE="50.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="174" TOTAL_2="181" WEIGHT="99.99999999999999" Z="0.08328390673259019">
<NAME>All-cause mortality</NAME>
<GROUP_LABEL_1>Y-set systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="10.3215366092072" CI_START="0.32755329035211095" EFFECT_SIZE="1.8387096774193548" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="1.0137443572933422" LOG_CI_START="-0.48471803361690463" LOG_EFFECT_SIZE="0.2645131618382187" ORDER="3924" O_E="0.0" SE="0.880204225929142" STUDY_ID="STD-Cheng-1994" TOTAL_1="31" TOTAL_2="38" VAR="0.7747594793435201" WEIGHT="19.38258598339051"/>
<DICH_DATA CI_END="5.899692445778291" CI_START="0.321417508195463" EFFECT_SIZE="1.3770491803278688" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7708293722213256" LOG_CI_START="-0.4929304701190965" LOG_EFFECT_SIZE="0.13894945105111461" ORDER="3925" O_E="0.0" SE="0.7423387871028744" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.5510668748373666" WEIGHT="27.250489750911772"/>
<DICH_DATA CI_END="5.083060192649951" CI_START="0.04918297059741634" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="3926" O_E="0.0" SE="1.1832159566199232" STUDY_ID="STD-Li-1996" TOTAL_1="20" TOTAL_2="20" VAR="1.4" WEIGHT="10.726315874873315"/>
<DICH_DATA CI_END="19.62529844584953" CI_START="0.17913740316868929" EFFECT_SIZE="1.875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2928162698707966" LOG_CI_START="-0.7468137257433215" LOG_EFFECT_SIZE="0.27300127206373764" ORDER="3927" O_E="0.0" SE="1.1980887557550428" STUDY_ID="STD-Maiorca-1983" TOTAL_1="32" TOTAL_2="30" VAR="1.4354166666666666" WEIGHT="10.461660766204453"/>
<DICH_DATA CI_END="2.288930488946035" CI_START="0.15727869489202628" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35963260406574094" LOG_CI_START="-0.8033301032984537" LOG_EFFECT_SIZE="-0.2218487496163564" ORDER="3928" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.4666666666666667" WEIGHT="32.17894762461994"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-11-20 12:24:23 +1100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Double bag systems versus standard systems</NAME>
<DICH_OUTCOME CHI2="1.724401313870145E-5" CI_END="0.6221707935885237" CI_START="0.2945700441354462" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4281038169967152" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="41" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.20609037972852234" LOG_CI_START="-0.5308114201822994" LOG_EFFECT_SIZE="-0.36845089995541086" METHOD="MH" MODIFIED="2013-11-20 12:23:45 +1100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9966867211680902" P_Q="1.0" P_Z="8.674586204242388E-6" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="101" TOTAL_2="69" WEIGHT="100.0" Z="4.447820769327521">
<NAME>Number of patients with peritonitis</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8179007272020935" CI_START="0.22456694716004522" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="21" LOG_CI_END="-0.08729940567426248" LOG_CI_START="-0.6486541649149263" LOG_EFFECT_SIZE="-0.36797678529459443" ORDER="3929" O_E="0.0" SE="0.3297425643288393" STUDY_ID="STD-Dryden-1992" TOTAL_1="40" TOTAL_2="40" VAR="0.10873015873015873" WEIGHT="33.46154902122285"/>
<DICH_DATA CI_END="0.6766317629905534" CI_START="0.27056334762568846" EFFECT_SIZE="0.4278688524590164" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="20" LOG_CI_END="-0.16964761906984582" LOG_CI_START="-0.5677310362751263" LOG_EFFECT_SIZE="-0.3686893276724861" ORDER="3930" O_E="0.0" SE="0.23383616981107752" STUDY_ID="STD-Monteon-1998" TOTAL_1="61" TOTAL_2="29" VAR="0.05467935431191508" WEIGHT="66.53845097877715"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.792105621007996" CI_END="0.47451499609208153" CI_START="0.1976401906997832" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3062404844522452" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="112" I2="44.19971745652271" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-0.3237500580161841" LOG_CI_START="-0.7041247357387856" LOG_EFFECT_SIZE="-0.513937396877485" METHOD="MH" MODIFIED="2013-11-20 12:23:54 +1100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.18066996306652783" P_Q="1.0" P_Z="1.181400398216091E-7" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="USER" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.044190747146293466" TOTALS="YES" TOTAL_1="1209" TOTAL_2="901" WEIGHT="100.0" Z="5.296350399659034">
<NAME>Peritonitis rate</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.38638384142672877" CI_START="0.15788567693807068" EFFECT_SIZE="0.2469908386187456" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="55" LOG_CI_END="-0.4129810440731661" LOG_CI_START="-0.801657266501544" LOG_EFFECT_SIZE="-0.607319155287355" ORDER="4" O_E="0.0" SE="0.22831033703275969" STUDY_ID="STD-Monteon-1998" TOTAL_1="645" TOTAL_2="337" VAR="0.05212560999601232" WEIGHT="51.832045766977714"/>
<DICH_DATA CI_END="0.6224363760133664" CI_START="0.23933195303587265" EFFECT_SIZE="0.38596491228070173" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="57" LOG_CI_END="-0.20590503452697217" LOG_CI_START="-0.6209993151735982" LOG_EFFECT_SIZE="-0.4134521748502852" ORDER="3931" O_E="0.0" SE="0.2438284352016559" STUDY_ID="STD-Dryden-1992" TOTAL_1="564" TOTAL_2="564" VAR="0.059452305812888115" WEIGHT="48.16795423302229"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:24:03 +1100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="20.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients switched to HD</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.439679023172555" CI_START="0.06476818582168423" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.188638267507881" LOG_CI_START="-1.188638267507881" LOG_EFFECT_SIZE="0.0" ORDER="3933" O_E="0.0" SE="1.3964240043768943" STUDY_ID="STD-Dryden-1992" TOTAL_1="40" TOTAL_2="40" VAR="1.9500000000000002" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:24:14 +1100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with exit site infection</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.138274863843685" CI_START="0.17923860222716867" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.49669097832768017" LOG_CI_START="-0.7465684515442799" LOG_EFFECT_SIZE="-0.12493873660829995" ORDER="3934" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Dryden-1992" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:24:23 +1100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>All-cause mortality</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.660501214038062" CI_START="0.2145691963319019" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6684326254422859" LOG_CI_START="-0.6684326254422858" LOG_EFFECT_SIZE="0.0" ORDER="3935" O_E="0.0" SE="0.7852812659593164" STUDY_ID="STD-Dryden-1992" TOTAL_1="40" TOTAL_2="40" VAR="0.6166666666666666" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-11-20 12:26:13 +1100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Y-set or double bag systems versus standard systems</NAME>
<DICH_OUTCOME CHI2="2.186581095605483" CI_END="0.6807208794697912" CI_START="0.4860399605722793" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5752021813399395" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="158" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-0.16703092825621113" LOG_CI_START="-0.31332802303689533" LOG_EFFECT_SIZE="-0.2401794756465532" METHOD="MH" MODIFIED="2013-11-20 12:24:37 +1100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9487957177570094" P_Q="1.0" P_Z="1.2311577702799388E-10" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="363" TOTAL_2="263" WEIGHT="100.00000000000001" Z="6.435440468570567">
<NAME>Number of patients with peritonitis</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8600260571329564" CI_START="0.31006291655039697" EFFECT_SIZE="0.5163934426229508" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="30" LOG_CI_END="-0.06548839027082547" LOG_CI_START="-0.5085501721715076" LOG_EFFECT_SIZE="-0.2870192812211665" ORDER="3936" O_E="0.0" SE="0.2602566838796524" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.06773354150403331" WEIGHT="10.902919964674796"/>
<DICH_DATA CI_END="0.8179007272020935" CI_START="0.22456694716004522" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="21" LOG_CI_END="-0.08729940567426248" LOG_CI_START="-0.6486541649149263" LOG_EFFECT_SIZE="-0.36797678529459443" ORDER="3937" O_E="0.0" SE="0.3297425643288393" STUDY_ID="STD-Dryden-1992" TOTAL_1="40" TOTAL_2="40" VAR="0.10873015873015873" WEIGHT="6.791982928813808"/>
<DICH_DATA CI_END="1.3032399154297964" CI_START="0.3107322549681106" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.11502437300812106" LOG_CI_START="-0.5076136632960575" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="3938" O_E="0.0" SE="0.36574066463306176" STUDY_ID="STD-Li-1996" TOTAL_1="20" TOTAL_2="20" VAR="0.13376623376623376" WEIGHT="5.520775767919314"/>
<DICH_DATA CI_END="0.8893675955887811" CI_START="0.38364826341508557" EFFECT_SIZE="0.5841269841269842" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="18" LOG_CI_END="-0.050918698266167704" LOG_CI_START="-0.41606676329396036" LOG_EFFECT_SIZE="-0.23349273078006402" ORDER="3939" O_E="0.0" SE="0.2144897809093985" STUDY_ID="STD-Lindholm-1988" TOTAL_1="35" TOTAL_2="23" VAR="0.04600586611456177" WEIGHT="16.0521569163265"/>
<DICH_DATA CI_END="1.006535329870023" CI_START="0.3021451911954777" EFFECT_SIZE="0.5514705882352942" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="17" LOG_CI_END="0.0028290234356131497" LOG_CI_START="-0.5197843133926481" LOG_EFFECT_SIZE="-0.25847764497851744" ORDER="3940" O_E="0.0" SE="0.30698566103066016" STUDY_ID="STD-Maiorca-1983" TOTAL_1="32" TOTAL_2="30" VAR="0.09424019607843137" WEIGHT="7.836288682250225"/>
<DICH_DATA CI_END="0.8928485354944184" CI_START="0.4750572369511378" EFFECT_SIZE="0.6512711864406779" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="20" LOG_CI_END="-0.049222209396113326" LOG_CI_START="-0.3232540615446096" LOG_EFFECT_SIZE="-0.18623813547036147" ORDER="3941" O_E="0.0" SE="0.16096766643157187" STUDY_ID="STD-Monteon-1998" TOTAL_1="118" TOTAL_2="29" VAR="0.025910589636425792" WEIGHT="28.50160464523973"/>
<DICH_DATA CI_END="0.7740885352276816" CI_START="0.34732649020251843" EFFECT_SIZE="0.5185185185185185" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="27" LOG_CI_END="-0.11120936468932852" LOG_CI_START="-0.4592620922721701" LOG_EFFECT_SIZE="-0.2852357284807493" ORDER="3942" O_E="0.0" SE="0.20444789507094907" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.0417989417989418" WEIGHT="17.667753061661234"/>
<DICH_DATA CI_END="1.2762878654636114" CI_START="0.34823213200652037" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="14" LOG_CI_END="0.10594864012372557" LOG_CI_START="-0.45813115823508804" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="3943" O_E="0.0" SE="0.33134326579600165" STUDY_ID="STD-Rottembourg-1987" TOTAL_1="27" TOTAL_2="28" VAR="0.10978835978835978" WEIGHT="6.726518033114399"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="26.7773839171933" CI_END="0.7275921659476517" CI_START="0.41860277376617294" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.551880511375628" ESTIMABLE="YES" EVENTS_1="232" EVENTS_2="413" I2="62.65505237209087" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-0.1381119856723557" LOG_CI_START="-0.3781978982444611" LOG_EFFECT_SIZE="-0.2581549419584084" METHOD="MH" MODIFIED="2013-11-20 12:24:44 +1100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0028240153954322" P_Q="1.0" P_Z="2.4983971092118835E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.12834306867021822" TOTALS="YES" TOTAL_1="4901" TOTAL_2="5181" WEIGHT="100.00000000000001" Z="4.214944419261155">
<NAME>Peritonitis rate</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2548489517821195" CI_START="0.5123991361546122" EFFECT_SIZE="0.8018625311720698" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="64" LOG_CI_END="0.09859145222699932" LOG_CI_START="-0.29039161109675293" LOG_EFFECT_SIZE="-0.09590007943487679" ORDER="3944" O_E="0.0" SE="0.22849057689358954" STUDY_ID="STD-Cheng-1994" TOTAL_1="802" TOTAL_2="1583" VAR="0.05220794372916535" WEIGHT="11.015612033623162"/>
<DICH_DATA CI_END="0.7595362607794666" CI_START="0.28057647383743145" EFFECT_SIZE="0.4616362266993033" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="47" LOG_CI_END="-0.11945148779129472" LOG_CI_START="-0.5519487471028417" LOG_EFFECT_SIZE="-0.3357001174470682" ORDER="3945" O_E="0.0" SE="0.2540510310155642" STUDY_ID="STD-Churchill-1989" TOTAL_1="452" TOTAL_2="467" VAR="0.06454192636007115" WEIGHT="10.311221484891417"/>
<DICH_DATA CI_END="0.6907255316983483" CI_START="0.13083123526040566" EFFECT_SIZE="0.3006134969325153" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="23" LOG_CI_END="-0.1606944906121063" LOG_CI_START="-0.883288558138782" LOG_EFFECT_SIZE="-0.5219915243754442" ORDER="3946" O_E="0.0" SE="0.4244553321634911" STUDY_ID="STD-Harris-1996" TOTAL_1="326" TOTAL_2="322" VAR="0.18016232900201956" WEIGHT="6.446823685666983"/>
<DICH_DATA CI_END="7.797934696063181" CI_START="1.0768009318347602" EFFECT_SIZE="2.897727272727273" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="5" LOG_CI_END="0.8919795938606663" LOG_CI_START="0.032135422706906926" LOG_EFFECT_SIZE="0.46205750828378656" ORDER="3947" O_E="0.0" SE="0.5050767224330102" STUDY_ID="STD-Kiernan-1995" TOTAL_1="176" TOTAL_2="170" VAR="0.25510249554367204" WEIGHT="5.186863770211917"/>
<DICH_DATA CI_END="1.3068553037610986" CI_START="0.3453718351832087" EFFECT_SIZE="0.6718266253869969" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.11622750475202598" LOG_CI_START="-0.46171308171717274" LOG_EFFECT_SIZE="-0.17274278848257338" ORDER="3948" O_E="0.0" SE="0.33948516134404955" STUDY_ID="STD-Li-1996" TOTAL_1="238" TOTAL_2="217" VAR="0.11525017477279537" WEIGHT="8.164758089174072"/>
<DICH_DATA CI_END="1.4914353665255353" CI_START="0.5161127001929926" EFFECT_SIZE="0.8773532550693703" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="25" LOG_CI_END="0.17360443733634948" LOG_CI_START="-0.28725545393940166" LOG_EFFECT_SIZE="-0.05682550830152611" ORDER="3949" O_E="0.0" SE="0.27071138142863027" STUDY_ID="STD-Li-1999" TOTAL_1="937" TOTAL_2="734" VAR="0.07328465203499734" WEIGHT="9.864119367680019"/>
<DICH_DATA CI_END="0.6934879289478691" CI_START="0.19510126803279051" EFFECT_SIZE="0.36783199195171024" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.15896109398068367" LOG_CI_START="-0.7097399079614317" LOG_EFFECT_SIZE="-0.43435050097105765" ORDER="3950" O_E="0.0" SE="0.3235302017313914" STUDY_ID="STD-Lindholm-1988" TOTAL_1="284" TOTAL_2="225" VAR="0.10467179143235482" WEIGHT="8.535420891156857"/>
<DICH_DATA CI_END="0.6718731624632677" CI_START="0.1752167706166355" EFFECT_SIZE="0.34310850439882695" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="31" LOG_CI_END="-0.172712706174577" LOG_CI_START="-0.7564243283180953" LOG_EFFECT_SIZE="-0.46456851724633613" ORDER="3951" O_E="0.0" SE="0.3428750962662322" STUDY_ID="STD-Maiorca-1983" TOTAL_1="363" TOTAL_2="351" VAR="0.11756333163957798" WEIGHT="8.08795502013724"/>
<DICH_DATA CI_END="0.7360977438007774" CI_START="0.3680472754966758" EFFECT_SIZE="0.5204985774285327" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="55" LOG_CI_END="-0.1330645134140937" LOG_CI_START="-0.4340963928247182" LOG_EFFECT_SIZE="-0.28358045311940594" ORDER="3952" O_E="0.0" SE="0.17682761609763642" STUDY_ID="STD-Monteon-1998" TOTAL_1="671" TOTAL_2="337" VAR="0.031268005814773084" WEIGHT="12.460788897555569"/>
<DICH_DATA CI_END="0.5467071977654312" CI_START="0.24461772991495542" EFFECT_SIZE="0.3656969696969697" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="88" LOG_CI_END="-0.26224520829386244" LOG_CI_START="-0.6115120684560109" LOG_EFFECT_SIZE="-0.4368786383749367" ORDER="3953" O_E="0.0" SE="0.2051610825580871" STUDY_ID="STD-Owen-1992" TOTAL_1="375" TOTAL_2="431" VAR="0.04209106979640623" WEIGHT="11.669492525166664"/>
<DICH_DATA CI_END="1.0271699534937255" CI_START="0.27577917583898554" EFFECT_SIZE="0.5322331098504384" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="28" LOG_CI_END="0.01164230704221668" LOG_CI_START="-0.5594385306172425" LOG_EFFECT_SIZE="-0.27389811178751283" ORDER="3954" O_E="0.0" SE="0.3354557109369043" STUDY_ID="STD-Rottembourg-1987" TOTAL_1="277" TOTAL_2="344" VAR="0.1125305340001839" WEIGHT="8.256944234736116"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.22868498513283492" CI_END="1.4227140584892812" CI_START="0.7096725325782653" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0048189334515898" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="40" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.1531176229945151" LOG_CI_START="-0.14894200353614012" LOG_EFFECT_SIZE="0.0020878097291874616" METHOD="MH" MODIFIED="2013-11-20 12:24:56 +1100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8919524193051094" P_Q="1.0" P_Z="0.9783846012710697" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="131" TOTAL_2="133" WEIGHT="100.00000000000001" Z="0.02709419939883634">
<NAME>Number of patients with exit-site/tunnel infection</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5751847038249802" CI_START="0.6195546668044932" EFFECT_SIZE="0.9878831076265147" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="23" LOG_CI_END="0.19733148583914029" LOG_CI_START="-0.20792036734428418" LOG_EFFECT_SIZE="-0.005294440752571952" ORDER="3955" O_E="0.0" SE="0.23804694458896963" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.056666347828143976" WEIGHT="55.55655952424983"/>
<DICH_DATA CI_END="3.138274863843685" CI_START="0.17923860222716867" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.49669097832768017" LOG_CI_START="-0.7465684515442799" LOG_EFFECT_SIZE="-0.12493873660829995" ORDER="3956" O_E="0.0" SE="0.7302967433402214" STUDY_ID="STD-Dryden-1992" TOTAL_1="40" TOTAL_2="40" VAR="0.5333333333333332" WEIGHT="5.902851236505237"/>
<DICH_DATA CI_END="1.8856585761492402" CI_START="0.615044169861256" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.2754630606613981" LOG_CI_START="-0.21109369391859562" LOG_EFFECT_SIZE="0.032184683371401235" ORDER="3957" O_E="0.0" SE="0.2858058461350672" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.0816849816849817" WEIGHT="38.540589239244945"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9595592745461476" CI_END="1.6926808692953812" CI_START="0.9067786605114475" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2389055215523976" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="91" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="0.22857508582989722" LOG_CI_START="-0.04249870880486403" LOG_EFFECT_SIZE="0.0930381885125166" METHOD="MH" MODIFIED="2013-11-20 12:25:05 +1100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.32729813260642693" P_Q="1.0" P_Z="0.17849572135252478" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1041" TOTAL_2="1800" WEIGHT="99.99999999999999" Z="1.3454011585079781">
<NAME>Exit-site/tunnel infection rate</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.8348324217187004" CI_START="0.9413514924563906" EFFECT_SIZE="1.3142382731423827" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="81" LOG_CI_END="0.263596405565636" LOG_CI_START="-0.02624818450964856" LOG_EFFECT_SIZE="0.11867411052799373" ORDER="3958" O_E="0.0" SE="0.17025614696408245" STUDY_ID="STD-Cheng-1994" TOTAL_1="803" TOTAL_2="1583" VAR="0.028987155579055242" WEIGHT="87.46708904163727"/>
<DICH_DATA CI_END="1.981425977526384" CI_START="0.33983861095015233" EFFECT_SIZE="0.8205882352941176" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.2969778525206713" LOG_CI_START="-0.46872728005798653" LOG_EFFECT_SIZE="-0.08587471376865759" ORDER="3959" O_E="0.0" SE="0.44977898517823905" STUDY_ID="STD-Li-1996" TOTAL_1="238" TOTAL_2="217" VAR="0.2023011355079666" WEIGHT="12.532910958362725"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:25:15 +1100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="50.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients who had CAPD catheter removed</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.938902847851195" CI_START="0.03780700379134716" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.46818522971347326" LOG_CI_START="-1.4224277391527982" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="3960" O_E="0.0" SE="1.1105554165971787" STUDY_ID="STD-Li-1996" TOTAL_1="20" TOTAL_2="20" VAR="1.2333333333333332" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3447534018942141" CI_END="1.4577672615177324" CI_START="0.7553833155813424" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0493679370703102" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="34" I2="0.0" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="0.16368819263296647" LOG_CI_START="-0.1218326118184992" LOG_EFFECT_SIZE="0.020927790407233603" METHOD="MH" MODIFIED="2013-11-20 12:25:35 +1100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.5570984245040669" P_Q="1.0" P_Z="0.7738684008092404" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="93" WEIGHT="100.0" Z="0.2873185759824595">
<NAME>Number of patients no longer on allocated treatment for whatever reason</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6881852263708894" CI_START="0.4837460586191216" EFFECT_SIZE="0.9036885245901639" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.2274200953569103" LOG_CI_START="-0.3153825604266544" LOG_EFFECT_SIZE="-0.04398123253487209" ORDER="3961" O_E="0.0" SE="0.3188449669237461" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.10166211293260473" WEIGHT="27.66888060910416"/>
<DICH_DATA CI_END="1.6353725305206617" CI_START="0.754915395846543" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="18" LOG_CI_END="0.21361669859922858" LOG_CI_START="-0.12210171747787829" LOG_EFFECT_SIZE="0.04575749056067514" ORDER="3962" O_E="0.0" SE="0.19720265943665385" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.03888888888888888" WEIGHT="72.33111939089584"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.21792433776008" CI_END="1.0861345428068432" CI_START="0.21454460685699026" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4827259144486558" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-003.07" LOG_CI_END="0.03588362597052309" LOG_CI_START="-0.6684823981282231" LOG_EFFECT_SIZE="-0.31629938607885" METHOD="MH" MODIFIED="2013-11-20 12:25:43 +1100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.5439153417238993" P_Q="1.0" P_Z="0.07836289744660338" Q="0.0" RANDOM="YES" SCALE="20.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="131" TOTAL_2="133" WEIGHT="99.99999999999999" Z="1.7602649299840907">
<NAME>Number of patients switched to HD</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.3209434292632753" CI_START="0.2042557803362291" EFFECT_SIZE="0.6885245901639344" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3656645550796966" LOG_CI_START="-0.6898256443054298" LOG_EFFECT_SIZE="-0.16208054461286658" ORDER="3963" O_E="0.0" SE="0.620000167879574" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.3844002081706999" WEIGHT="44.53365989339077"/>
<DICH_DATA CI_END="15.439679023172555" CI_START="0.06476818582168423" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.188638267507881" LOG_CI_START="-1.188638267507881" LOG_EFFECT_SIZE="0.0" ORDER="3964" O_E="0.0" SE="1.3964240043768943" STUDY_ID="STD-Dryden-1992" TOTAL_1="40" TOTAL_2="40" VAR="1.9500000000000002" WEIGHT="8.778845196729517"/>
<DICH_DATA CI_END="0.9829906466729277" CI_START="0.09155733099253573" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="-0.007450614535779605" LOG_CI_START="-1.0383068760248957" LOG_EFFECT_SIZE="-0.5228787452803376" ORDER="3965" O_E="0.0" SE="0.6055300708194984" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.3666666666666667" WEIGHT="46.6874949098797"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="22" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-003.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:25:51 +1100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients hospitalised (all cause)</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5647755214808194" CI_START="0.8068905703637201" EFFECT_SIZE="1.1236559139784945" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="24" LOG_CI_END="0.19445204362389634" LOG_CI_START="-0.09318535983762101" LOG_EFFECT_SIZE="0.050633341893137646" ORDER="3966" O_E="0.0" SE="0.16895963462140562" STUDY_ID="STD-Cheng-1994" TOTAL_1="31" TOTAL_2="38" VAR="0.028547358131398887" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-003.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:25:58 +1100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients hospitalised (peritonitis)</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4448139847532715" CI_START="0.25999911972620016" EFFECT_SIZE="0.6129032258064516" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="12" LOG_CI_END="0.15981193664591378" LOG_CI_START="-0.5850281224088013" LOG_EFFECT_SIZE="-0.21260809288144372" ORDER="3967" O_E="0.0" SE="0.4375227377064954" STUDY_ID="STD-Cheng-1994" TOTAL_1="31" TOTAL_2="38" VAR="0.19142614601018676" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.8369803937682807" CI_END="2.0280097254213265" CI_START="0.5193654363076632" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0262934063315576" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-003.10" LOG_CI_END="0.30707003334704236" LOG_CI_START="-0.2845269559780464" LOG_EFFECT_SIZE="0.01127153868449803" METHOD="MH" MODIFIED="2013-11-20 12:26:13 +1100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.871210632964712" P_Q="1.0" P_Z="0.9404650755053519" Q="0.0" RANDOM="YES" SCALE="50.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="214" TOTAL_2="221" WEIGHT="100.00000000000001" Z="0.07468533569506189">
<NAME>All-cause mortality</NAME>
<GROUP_LABEL_1>Y-set or double bag</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard system</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Y-set or double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="10.3215366092072" CI_START="0.32755329035211095" EFFECT_SIZE="1.8387096774193548" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="1.0137443572933422" LOG_CI_START="-0.48471803361690463" LOG_EFFECT_SIZE="0.2645131618382187" ORDER="3968" O_E="0.0" SE="0.880204225929142" STUDY_ID="STD-Cheng-1994" TOTAL_1="31" TOTAL_2="38" VAR="0.7747594793435201" WEIGHT="15.586916747212172"/>
<DICH_DATA CI_END="5.899692445778291" CI_START="0.321417508195463" EFFECT_SIZE="1.3770491803278688" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7708293722213256" LOG_CI_START="-0.4929304701190965" LOG_EFFECT_SIZE="0.13894945105111461" ORDER="3969" O_E="0.0" SE="0.7423387871028744" STUDY_ID="STD-Churchill-1989" TOTAL_1="61" TOTAL_2="63" VAR="0.5510668748373666" WEIGHT="21.914058084519876"/>
<DICH_DATA CI_END="4.660501214038062" CI_START="0.2145691963319019" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6684326254422859" LOG_CI_START="-0.6684326254422858" LOG_EFFECT_SIZE="0.0" ORDER="3970" O_E="0.0" SE="0.7852812659593164" STUDY_ID="STD-Dryden-1992" TOTAL_1="40" TOTAL_2="40" VAR="0.6166666666666666" WEIGHT="19.58288351941767"/>
<DICH_DATA CI_END="5.083060192649951" CI_START="0.04918297059741634" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7061252525673394" LOG_CI_START="-1.3081852438953019" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="3971" O_E="0.0" SE="1.1832159566199232" STUDY_ID="STD-Li-1996" TOTAL_1="20" TOTAL_2="20" VAR="1.4" WEIGHT="8.625793931172069"/>
<DICH_DATA CI_END="19.62529844584953" CI_START="0.17913740316868929" EFFECT_SIZE="1.875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2928162698707966" LOG_CI_START="-0.7468137257433215" LOG_EFFECT_SIZE="0.27300127206373764" ORDER="3972" O_E="0.0" SE="1.1980887557550428" STUDY_ID="STD-Maiorca-1983" TOTAL_1="32" TOTAL_2="30" VAR="1.4354166666666666" WEIGHT="8.412965924162018"/>
<DICH_DATA CI_END="2.288930488946035" CI_START="0.15727869489202628" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35963260406574094" LOG_CI_START="-0.8033301032984537" LOG_EFFECT_SIZE="-0.2218487496163564" ORDER="3973" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Owen-1992" TOTAL_1="30" TOTAL_2="30" VAR="0.4666666666666667" WEIGHT="25.877381793516204"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2013-11-20 12:27:20 +1100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Double bag systems versus Y-set systems</NAME>
<DICH_OUTCOME CHI2="5.09078278479134" CI_END="1.0050429093595155" CI_START="0.3458440422428186" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5895660288724051" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="66" I2="60.71331100641381" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.0021846039458068437" LOG_CI_START="-0.4611197013886677" LOG_EFFECT_SIZE="-0.22946754872143046" METHOD="MH" MODIFIED="2013-11-20 12:26:26 +1100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.07844243107954085" P_Q="1.0" P_Z="0.05220002560079933" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.13096243758218468" TOTALS="YES" TOTAL_1="154" TOTAL_2="138" WEIGHT="100.0" Z="1.9414804737892772">
<NAME>Number of patients with peritonitis</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Y-set systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Y-set</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9492266590191605" CI_START="0.15115489620243014" EFFECT_SIZE="0.3787878787878788" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="-0.022630073128180783" LOG_CI_START="-0.8205777806114813" LOG_EFFECT_SIZE="-0.42160392686983106" ORDER="3974" O_E="0.0" SE="0.4687184332805461" STUDY_ID="STD-Harris-1996" TOTAL_1="33" TOTAL_2="30" VAR="0.21969696969696972" WEIGHT="21.121384448696624"/>
<DICH_DATA CI_END="1.5423512369404693" CI_START="0.5722501996853303" EFFECT_SIZE="0.9394736842105263" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="19" LOG_CI_END="0.1881832860981446" LOG_CI_START="-0.24241404710737852" LOG_EFFECT_SIZE="-0.027115380504616943" ORDER="3975" O_E="0.0" SE="0.2529350050160999" STUDY_ID="STD-Li-1999" TOTAL_1="60" TOTAL_2="51" VAR="0.06397611676249447" WEIGHT="37.99357277780729"/>
<DICH_DATA CI_END="0.7454948041200095" CI_START="0.30978068940316844" EFFECT_SIZE="0.48056206088992975" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="35" LOG_CI_END="-0.1275553791055168" LOG_CI_START="-0.5089456580649736" LOG_EFFECT_SIZE="-0.31825051858524517" ORDER="3976" O_E="0.0" SE="0.22403053777311363" STUDY_ID="STD-Monteon-1998" TOTAL_1="61" TOTAL_2="57" VAR="0.05018968185491049" WEIGHT="40.88504277349609"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.242157318732435" CI_END="1.6575253539324386" CI_START="0.4860238518271508" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8975504760287331" ESTIMABLE="YES" EVENTS_1="131" EVENTS_2="110" I2="75.4945152076299" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.21946018020727115" LOG_CI_START="-0.3133424170283825" LOG_EFFECT_SIZE="-0.04694111841055565" METHOD="MH" MODIFIED="2013-11-20 12:26:35 +1100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.006598052474172" P_Q="1.0" P_Z="0.7298278395465312" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.2769156975338553" TOTALS="YES" TOTAL_1="2422" TOTAL_2="1897" WEIGHT="100.0" Z="0.3453545532850591">
<NAME>Peritonitis rate</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Y-set systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Y-set</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.6907255316983483" CI_START="0.13083123526040566" EFFECT_SIZE="0.3006134969325153" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="23" LOG_CI_END="-0.1606944906121063" LOG_CI_START="-0.883288558138782" LOG_EFFECT_SIZE="-0.5219915243754442" ORDER="3977" O_E="0.0" SE="0.4244553321634911" STUDY_ID="STD-Harris-1996" TOTAL_1="326" TOTAL_2="322" VAR="0.18016232900201956" WEIGHT="21.429770835396063"/>
<DICH_DATA CI_END="7.797934696063181" CI_START="1.0768009318347602" EFFECT_SIZE="2.897727272727273" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="5" LOG_CI_END="0.8919795938606663" LOG_CI_START="0.032135422706906926" LOG_EFFECT_SIZE="0.46205750828378656" ORDER="3978" O_E="0.0" SE="0.5050767224330102" STUDY_ID="STD-Kiernan-1995" TOTAL_1="176" TOTAL_2="170" VAR="0.25510249554367204" WEIGHT="18.411169937437663"/>
<DICH_DATA CI_END="1.4914353665255353" CI_START="0.5161127001929926" EFFECT_SIZE="0.8773532550693703" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="25" LOG_CI_END="0.17360443733634948" LOG_CI_START="-0.28725545393940166" LOG_EFFECT_SIZE="-0.05682550830152611" ORDER="3979" O_E="0.0" SE="0.27071138142863027" STUDY_ID="STD-Li-1999" TOTAL_1="937" TOTAL_2="734" VAR="0.07328465203499734" WEIGHT="27.96992457208577"/>
<DICH_DATA CI_END="1.3416264999874354" CI_START="0.7013369222480542" EFFECT_SIZE="0.9700165979547036" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="57" LOG_CI_END="0.1276316279258851" LOG_CI_START="-0.15407329683985552" LOG_EFFECT_SIZE="-0.013220834456985206" ORDER="3980" O_E="0.0" SE="0.1654748672692632" STUDY_ID="STD-Monteon-1998" TOTAL_1="983" TOTAL_2="671" VAR="0.027381931697780273" WEIGHT="32.1891346550805"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.4433685163176175" CI_END="2.0599944284210157" CI_START="0.5234602960777044" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0384244283623563" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="60" I2="54.9891035898712" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.31386604575299776" LOG_CI_START="-0.28111625352341124" LOG_EFFECT_SIZE="0.016374896114793272" METHOD="MH" MODIFIED="2013-11-20 12:26:43 +1100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.10842644102656318" P_Q="1.0" P_Z="0.914088585278408" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.20465779749244134" TOTALS="YES" TOTAL_1="1439" TOTAL_2="1226" WEIGHT="100.0" Z="0.10788289559071318">
<NAME>Exit-site/tunnel infection rate</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Y-set systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Y-set</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6238747494865124" CI_START="0.1501979562158916" EFFECT_SIZE="0.4938650306748466" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.21055252878163835" LOG_CI_START="-0.823335976853817" LOG_EFFECT_SIZE="-0.30639172403608933" ORDER="3981" O_E="0.0" SE="0.6073112260409086" STUDY_ID="STD-Harris-1996" TOTAL_1="326" TOTAL_2="322" VAR="0.3688269252753115" WEIGHT="21.299109302493903"/>
<DICH_DATA CI_END="5.728551159325789" CI_START="0.8867093373691708" EFFECT_SIZE="2.253787878787879" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="6" LOG_CI_END="0.7580447959510689" LOG_CI_START="-0.052218718233631944" LOG_EFFECT_SIZE="0.3529130388587185" ORDER="3982" O_E="0.0" SE="0.475952799101175" STUDY_ID="STD-Kiernan-1995" TOTAL_1="176" TOTAL_2="170" VAR="0.22653106697224343" WEIGHT="28.32798989070645"/>
<DICH_DATA CI_END="1.3463135205279555" CI_START="0.6281141642803237" EFFECT_SIZE="0.9195860980928959" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="46" LOG_CI_END="0.12914620727278656" LOG_CI_START="-0.20196141293341313" LOG_EFFECT_SIZE="-0.036407602830313295" ORDER="3983" O_E="0.0" SE="0.19449425511827534" STUDY_ID="STD-Li-1999" TOTAL_1="937" TOTAL_2="734" VAR="0.03782801527401277" WEIGHT="50.37290080679964"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4003879922119435" CI_END="3.10090659726821" CI_START="0.028868996696656476" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.29919903461270764" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" I2="28.59121860788894" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.49148868500484477" LOG_CI_START="-1.5395683091804944" LOG_EFFECT_SIZE="-0.5240398120878248" METHOD="MH" MODIFIED="2013-11-20 12:26:52 +1100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.23665883600456872" P_Q="1.0" P_Z="0.3118280330523341" Q="0.0" RANDOM="YES" SCALE="200.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.8149022274391571" TOTALS="YES" TOTAL_1="74" TOTAL_2="71" WEIGHT="100.0" Z="1.0113937335069672">
<NAME>Number of patients switched to HD</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Y-set systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Y-set or double bag</GRAPH_LABEL_2>
<DICH_DATA CI_END="13.902157778612597" CI_START="0.05944733861840928" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.143082213104131" LOG_CI_START="-1.225867583420581" LOG_EFFECT_SIZE="-0.04139268515822506" ORDER="3984" O_E="0.0" SE="1.391532836969231" STUDY_ID="STD-Harris-1996" TOTAL_1="33" TOTAL_2="30" VAR="1.9363636363636363" WEIGHT="51.735287307040025"/>
<DICH_DATA CI_END="1.592645078495987" CI_START="0.005189142842623727" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2021190039087572" LOG_CI_START="-2.2849043742252073" LOG_EFFECT_SIZE="-1.041392685158225" ORDER="3985" O_E="0.0" SE="1.4608898432801614" STUDY_ID="STD-Kiernan-1995" TOTAL_1="41" TOTAL_2="41" VAR="2.134199134199134" WEIGHT="48.26471269295997"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:27:01 +1100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="41" TOTAL_2="41" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients no longer on allocated treatment for whatever reason</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Y-set systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Y-set</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0488963380360434" CI_START="0.12606718143974857" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.02073256918164102" LOG_CI_START="-0.8993979568421662" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="3986" O_E="0.0" SE="0.5404892257059458" STUDY_ID="STD-Kiernan-1995" TOTAL_1="41" TOTAL_2="41" VAR="0.29212860310421285" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-004.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-20 12:27:11 +1100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="200.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="33" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients who had CAPD catheter removed</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Y-set systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Y-set</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.8063665861210592" CI_START="0.00568165218059946" EFFECT_SIZE="0.10130718954248366" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2568058911456305" LOG_CI_START="-2.2455253564402446" LOG_EFFECT_SIZE="-0.9943597326473073" ORDER="3987" O_E="0.0" SE="1.4698817615713895" STUDY_ID="STD-Harris-1996" TOTAL_1="33" TOTAL_2="30" VAR="2.160552393000211" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.47676141326774135" CI_END="3.428741951445288" CI_START="0.2454235908164733" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9173299088696413" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-004.07" LOG_CI_END="0.535134801160307" LOG_CI_START="-0.6100836939765962" LOG_EFFECT_SIZE="-0.037474446408144665" METHOD="MH" MODIFIED="2013-11-20 12:27:20 +1100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.4898929759832724" P_Q="1.0" P_Z="0.8979353371408914" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="101" TOTAL_2="92" WEIGHT="99.99999999999999" Z="0.1282699600337133">
<NAME>All-cause mortality</NAME>
<GROUP_LABEL_1>Double bag systems</GROUP_LABEL_1>
<GROUP_LABEL_2>Y-set systems</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours double bag</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Y-set</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.950938032119094" CI_START="0.013974591508858441" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9004183686742379" LOG_CI_START="-1.8546608781135625" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="3988" O_E="0.0" SE="1.618347187425374" STUDY_ID="STD-Kiernan-1995" TOTAL_1="41" TOTAL_2="41" VAR="2.619047619047619" WEIGHT="17.27859860214102"/>
<DICH_DATA CI_END="4.829870396894981" CI_START="0.2659376626897039" EFFECT_SIZE="1.1333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6839354771969534" LOG_CI_START="-0.5752201525517682" LOG_EFFECT_SIZE="0.054357662322592676" ORDER="3989" O_E="0.0" SE="0.7396342498352896" STUDY_ID="STD-Li-1999" TOTAL_1="60" TOTAL_2="51" VAR="0.5470588235294116" WEIGHT="82.72140139785897"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-11-20 11:41:06 +1100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2013-11-20 11:41:06 +1100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-10-22 10:53:48 +1100" MODIFIED_BY="[Empty name]">Electronic search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2013-11-20 11:41:06 +1100" MODIFIED_BY="[Empty name]">
<TABLE COLS="2" ROWS="4">
<TR>
<TH>
<P>Database</P>
</TH>
<TH>
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD>
<P>CENTRAL</P>
</TD>
<TD>
<P>#1 ("Y" near/2 set):ti,ab,kw</P>
<P>#2 (y-tub*):ti,ab,kw</P>
<P>#3 (y-connect* or (y near/1 connect*)):ti,ab,kw</P>
<P>#4 (disconnect* near/2 system*):ti,ab,kw</P>
<P>#5 (twin near/3 bag*):ti,ab,kw</P>
<P>#6 (double near/3 bag*):ti,ab,kw</P>
<P>#7 "O-set":ti,ab,kw</P>
<P>#8 conventional:ti,ab,kw</P>
<P>#9 spike*:ti,ab,kw</P>
<P>#10 b-set:ti,ab,kw</P>
<P>#11 {or #1-#10}</P>
<P>#12 "continuous ambulatory peritoneal dialysis":ti,ab,kw</P>
<P>#13 CAPD:ti,ab,kw</P>
<P>#14 peritonitis:ti,ab,kw</P>
<P>#15 {or #12-#14}</P>
<P>#16 #11 and #15</P>
</TD>
</TR>
<TR>
<TD>
<P>MEDLINE</P>
</TD>
<TD>
<OL>
<LI>(disconnect* adj2 system*).tw.</LI>
<LI>(twin adj3 bag*).tw.</LI>
<LI>conventional.tw.</LI>
<LI>spike*.tw.</LI>
<LI>b-set.tw.</LI>
<LI>(y adj2 set).tw.</LI>
<LI>y-connect*.tw.</LI>
<LI>o-set.tw.</LI>
<LI>o-system.tw.</LI>
<LI>(double adj3 bag*).tw.</LI>
<LI>or/1-10</LI>
<LI>Peritoneal Dialysis, Continuous Ambulatory/</LI>
<LI>continuous ambulatory peritoneal dialysis.tw.</LI>
<LI>CAPD.tw.</LI>
<LI>peritonitis.mp.</LI>
<LI>or/12-15</LI>
<LI>and/11,16</LI>
</OL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>EMBASE</P>
</TD>
<TD>
<OL>
<LI>(disconnect* adj2 system*).tw.</LI>
<LI>(twin adj3 bag*).tw.</LI>
<LI>conventional.tw.</LI>
<LI>spike*.tw.</LI>
<LI>b-set.tw.</LI>
<LI>(y adj2 set).tw.</LI>
<LI>y-connect*.tw.</LI>
<LI>o-set.tw.</LI>
<LI>o-system.tw.</LI>
<LI>(double adj3 bag*).tw.</LI>
<LI>or/1-10</LI>
<LI>continuous ambulatory peritoneal dialysis/</LI>
<LI>CAPD.tw.</LI>
<LI>continuous ambulatory peritoneal dialysis.tw.</LI>
<LI>peritonitis.mp.</LI>
<LI>or/12-15</LI>
<LI>and/11,16</LI>
</OL>
<P/>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>